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ABSTRACT
In the quest to understand cell behavior and cure genetic diseases such as cancer, the funda-
mental approach being taken is undergoing a gradual change. It is becoming more accept-
able to view these diseases as an engineering problem, and systems engineering approaches
are being deployed to tackle genetic diseases. In this light, we believe that logic synthe-
sis techniques can play a very important role. Several techniques from the field of logic
synthesis can be adapted to assist in the arguably huge effort of modeling cell behavior,
inferring biological networks, and controlling genetic diseases. Genes interact with other
genes in a Gene Regulatory Network (GRN) and can be modeled as a Boolean Network
(BN) or equivalently as a Finite State Machine (FSM). As the expression of genes deter-
mine cell behavior, important problems include (i) inferring the GRN from observed gene
expression data from biological measurements, and (ii) using the inferred GRN to explain
how genetic diseases occur and determine the ”best” therapy towards treatment of disease.
We report results on the application of logic synthesis techniques that we have devel-
oped to address both these problems. In the first technique, we present Boolean Satisfi-
ability (SAT) based approaches to infer the predictor (logical support) of each gene that
regulates melanoma, using gene expression data from patients who are suffering from the
disease. From the output of such a tool, biologists can construct targeted experiments to
understand the logic functions that regulate a particular target gene. Our second technique
builds upon the first, in which we use a logic synthesis technique, implemented using SAT,
to determine gene regulating functions for predictors and gene expression data. This tech-
nique determines a BN (or family of BNs) to describe the GRN and is validated on a syn-
thetic network and the p53 network. The first two techniques assume binary valued gene
expression data. In the third technique, we utilize continuous (analog) expression data,
ii
and present an algorithm to infer and rank predictors using modified Zhegalkin polynomi-
als. We demonstrate our method to rank predictors for genes in the mutated mammalian
and melanoma networks. The final technique assumes that the GRN is known, and uses
weighted partial Max-SAT (WPMS) towards cancer therapy. In this technique, the GRN
is assumed to be known. Cancer is modeled using a stuck-at fault model, and ATPG tech-
niques are used to characterize genes leading to cancer and select drugs to treat cancer.
To steer the GRN state towards a desirable healthy state, the optimal selection of drugs is
formulated using WPMS. Our techniques can be used to find a set of drugs with the least
side-effects, and is demonstrated in the context of growth factor pathways for colon cancer.
iii
To my family
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CHAPTER I
INTRODUCTION
I-A. Genomics
Recently, there have been many advances in biology towards our understanding of the
human genome. Improvements in DNA/RNA sequencing have allowed rapid and inexpen-
sive sequencing of a person’s genome and improvements in microarray technology have
allowed biologists and clinicians to rapidly measure tens of thousands of gene expressions
at once. These advances have brought new interest to the field of genomics, which aims
to study genes as a collective system in a Gene Regulatory Network (GRN), rather than
to study genes individually. Genomics is important to biology and medicine as both cel-
lular control and its failure – disease – is a result of the activity of many genes interacting
simultaneously.
Towards the treatment of genetic diseases, genomics has three main goals.
1. Understand how cells operate and the way the cellular system fails
2. Identify key genes for specific diseases
3. Use models to guide drug development and therapy for such diseases
There has been recent work in the genomics area from various researchers in the signal
processing, computational biology, and data-mining communities, in addition to the work
of biologists and medical practitioners. We recognize that genomics, or the system of gene
interactions, can be modeled as a Finite State Machine (FSM) in logic-speak, and thus is
amenable to many powerful logic synthesis techniques. The motivation for our research is
to determine how logic synthesis can be used in inferring and controlling the GRN, and to
increase the interest among the logic and CAD community towards the study of genomics.
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I-B. Cell Biology
In this section, we present an engineering-centric view of the biological organism, with an
overview of some of the relevant terminology and domain information.
I-B.1. Genome
In an organism, the basic unit of life is the cell. Practically all cell function is carried out by
large molecules called proteins. There exist many types of proteins, and they provide most
of the cell structure and cell function. Some examples of proteins are enzymes to promote
chemical reactions, signaling molecules for communication across cells, and molecules
with moving parts [1, 2]. Proteins can have complex shapes, allowing for many functions.
Each protein is made up of a chain of amino acids as determined by its corresponding
gene, and the shape is determined by its amino acid sequence [1, 2]. The unique shape of a
protein allows it to chemically bind to other molecules, including other proteins, that match
its specific shape.
The genetic information of each living organism is encoded in DNA (Deoxyribonu-
cleic acid). DNA is a molecule consisting of a sequence of 4 nucleotide bases: adenine,
guanine, cytosine, and thymine (often shortened to the letters A, G, C, and T respec-
tively) [3]. The actual sequence of the bases is the property that encodes the genetic in-
formation. The structure of DNA consists of two strands, each providing a copy of the
sequence. The two strands run in parallel and are connected to each other through base
pairing, wherein each base on one strand bonds with only one type of base on the other
strand. There are two types of base pairs, A-T and G-C. An example of the DNA structure
is shown in Figure I.1.
2
. . .
A G T C C A T C
C A G G T A GT
. . .
Fig. I.1. DNA structure
The DNA can be visualized as a string of characters, where each character is one of
the 4 nucelotide bases. Genes are short stretches (chunks) of DNA (Figure I.2) that produce
functional molecules proteins and RNA. The linear sequence of bases in a gene spells out
the sequence of amino acids in a protein.
Gene 2 Gene 4Gene 1 Gene 3
DNA
Fig. I.2. Genes consist of short stretches of DNA
When taken as a whole, the complete set of information in an organism’s DNA is
called the genome. Individual ”instances” of the same species have small variations in
their genome (which result in variations in characteristics of the human being for instance).
The entire genomes of several model organisms have been sequenced, yielding the entire
DNA sequence for those organisms. For instance, the human genome has been sequenced
and has been found to consist of approximately 3.2 billion base pairs in all and around
30,000 genes.
While DNA is comprised of 4 bases, proteins are an amino acid chain with 20 possi-
ble amino acids. The process of mapping a 4-letter alphabet (DNA) to 20-letter alphabet
(amino acid) takes place with the help of RNA in a process called transcription and transla-
tion (Figure I.3).
When a protein is needed by the cell, the nucleotide sequence of the gene is first copied
to another type of nucleic acid, RNA, which is similar to DNA but with the 4 nucleotide
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bases: A, G, C, U. The RNA strand then serves as a template for protein synthesis. A
specific molecule called polymerase latches onto the start site of the gene and slides along
the DNA, synthesizing the complementary RNA at the same time. This process of copying
gene DNA into RNA strands is referred to as transcription. When a gene is being tran-
scribed, it is said to be expressed, or turned ON. If no transcription is taking place, then the
gene is said to be not expressed, or turned OFF.
After the RNA strand is produced, the RNA nucleotide sequence has to be decoded to
produce the appropriate protein. This translation process takes place with the use of other
functional molecules called ribosomes among others, which read the RNA strand and bind
the complementary amino acids to form a chain. The resulting amino acid chain folds to
create the final protein.
Promoter
Transcription
start site stop site
Transcription
Folding
Translation
Transcription
DNA
RNA
Amino acid chain
Protein
Gene
Fig. I.3. Transcription and translation of gene to RNA and protein
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I-B.2. Gene Expression Regulation
While the genome of an organism encodes all functional molecules that are needed to
make and maintain its cells, not every gene needs to be expressed all the time. A cell can
regulate its genes and use its genes selectively, switching genes ON and OFF to produce
different proteins depending on the situation. Or in the case of multicellular organism, all
cells have the same genome and different genes can be expressed to create large variety
of cell types (i.e. skin cells, muscle cells, colon cells, etc.). One example to demonstrate
that the alteration of expression of single gene can trigger development of a different cell
is the study involving fruit flies and gene Ey [4], which is crucial for eye development.
In this study, Ey is expressed early in development (using artificial means) in cells that
normally go on to form legs. As a result, in these flies eyes developed in the middle of legs.
Another example of single gene expression affecting cell function is the β-globin gene,
which produces one of the hemo protein. Mutations in the β-globin gene [5] cause the
protein to have the wrong amino acid sequence and hence, different physical dimension.
When this protein binds with the other hemo protein groups, the resulting hemoglobin does
not have the correct shape to transport oxygen, leading to the disease sickle cell anemia.
Both these examples show how erroneous gene expression can affect normal cell operation
and disease.
Protein production can be controlled at different points throughout the transcription,
translation, and protein binding processes. Of interest to gene regulation and genomics
is the first type, transcription control. Each gene has a start site that indicates where tran-
scription will start. Upstream of the start site on the DNA is the promoter region (regulatory
DNA sequences as shown on Figure I.3) which are needed by the cell to switch the gene ON
or OFF [6]. These regulatory DNA sequences must be bound by gene regulatory proteins
which uniquely recognize these sequences. The gene regulatory proteins, when bounded,
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can either suppress or enhance transcription. Those proteins which turn OFF genes are
called repressors, which proteins that turn ON genes are activators. For example, when the
a repressor binds to the gene regulatory sequence, the polymerase molecule cannot attach
to the starting site, thus transcription cannot begin and the gene expression is turned off.
As shown in Figure I.4, gene G1 produces protein P1, which is a repressor for gene G2. So
if G1 is expressed (P1 is present), then gene G2 cannot produce protein P2. Otherwise, if
gene G1 is not expressed, then gene G2 can produce protein P2. In this manner, a complex
gene expression network can be formed.
Polymerase
DNA
G2
P1 repressor P2
G2 Promoter
Fig. I.4. Gene expression repression example
I-B.3. Gene Expression Measurement
As described in the previous section, cell function and control results from the interaction of
genes and its products: RNA and proteins. All three components, DNA (and genes), RNA,
and proteins, are involved in gene expression regulation and have high level of interaction.
This interaction allows a significant amount of information about the gene activity to be
available in each of the components. In industry and research, the focus is measurement
at the RNA level, from which the gene expression value can be inferred. In particular,
high-throughput applications such as expression microarrays have been recently developed
which allow for measurement of tens of thousands of RNA simultaneously.
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The expression microarray system is comprised of both biochemical and optical imag-
ing processes. A microarray is a slide plate with an array of thousands of different probes
attached to the surface in a grid pattern. Each probe is a single-stranded DNA correspond-
ing to a unique gene. The general steps (shown in Figure I.5) begin with extracting RNA
from cells, converting the RNA to single stranded cDNA (complementary DNA), attaching
fluorescent labels (markers) to the cDNAs, allowing the cDNAs to attach (bind) to their
complementary probes on the slide, washing the slide of any unbounded molecules, and
then detecting the fluorescence of the attached cDNA on the slide.
The principle of the microarray is that if a specific gene is expressed, then the corre-
sponding RNA is produced. The RNA is converted to cDNA and the fluorescent-marked
cDNA will attach to its complementary probe on the microarray. Those fluorescent-marked
cDNA that attach to probes will fluoresce (emit light when excited by a laser) and the in-
tensity of the fluorescence can be recorded as a digital image (for each probe on the mi-
croarray).
7
RNA
cDNA
gene expression
glass slide microarray
RNA extraction
cDNA conversion
and labeling
binding
laser and
imaging
Fig. I.5. Microarray process flow for measuring gene expression
Through analysis of the digital image, the intensities of fluorescence reflect RNA lev-
els, and in turn gene expression levels. The measurements of gene expression from mi-
croarrays can be expressed in the form of ratios or as raw intensity values, which can be
further processed with statistical software [7] to obtained normalized or binary expression
values. The development of microarrays and other measuring technologies have allowed
for snapshot measurements of the entire genome, driving research to focus on gene regula-
tion in the complete network, rather than just gene pair interactions.
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I-C. Gene Regulation Networks
A main focus of genomics is the understanding of the manner in which cells execute and
control the number of operations required for normal cellular function, and the ways in
which cell systems fail, causing disease. While classical approaches in molecular biol-
ogy have identified specific processes and interactions in the cell, they have not been able
to produce an overall formalism for cell operation. Many cell processes, functions, and
diseases are a result of highly complex and multivariate gene interaction, necessitating a
system or network view of the genome.
The gene regulatory network (GRN) is one systematic approach to characterize the cell
behavior through gene-to-gene interaction among a set of genes (i.e. how the expression of
a subset of genes affects the expression of another gene in the set). Several GRN models
have been developed, but all models have the same properties, in that they all represent
systems which characterize an interaction among a group of components as a whole, and
they all model a dynamical, time-varying physical process.
In particular, a GRN model describes the 1) topology (connectivity structure) of the
genes, and 2) the regulating functions of the genes. Both these aspects together deter-
mine the dynamical behavior of system. With an accurate GRN model, an analysis of the
topology and regulation functions can provide deep insight in the long-term behavior of
the system, and identify how the system can fail and lead to disease. Several models have
been proposed for the GRN such as Markov Chains [8, 9], Differential equations [10, 11],
Boolean Networks (BNs) [12, 13], Continuous Networks [14], and Stochastic Gene Net-
works [15]. Our research focuses on Boolean networks due to its significant adoption by
the research community. A benefit of using BNs is that they lend themselves to analysis
using logic synthesis techniques. Boolean networks are described in detail in the following
subsection.
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In addition to gene regulatory networks, RNA and protein regulatory networks are also
studied in genomics. RNA regulatory networks [16, 17] describe RNA interactions such as
splicing. After transcription, the RNA may undergo splicing where portions of the RNA are
kept, while other portions are removed. Some RNA have alternative splicing, which allows
RNA to produce different proteins. On the other hand, protein regulatory networks [18]
describe protein-protein interactions such as protein binding (for example, hemo protein
groups) or altering protein activity. Protein networks are also important to study as most
proteins perform various cell functions through interactions with other proteins.
I-C.1. Boolean Network
We utilize the Boolean Network (BN) model that was proposed by Kauffman in 1969 [12].
In a Boolean Network, the expression activity of a gene is represented as a binary value,
where 1 indicates the gene is ON (expressed) and producing gene-products, while 0 indi-
cates it is OFF (not expressed). Such a model cannot capture the continuous and stochastic
biochemical properties of protein and RNA production. However, it has been observed that
genes can typically be modeled as ON or OFF in any particular biochemical pathway [19].
A Boolean network is formally defined as a set of nodes {x1,x2, . . . ,xn} with Boolean
functions {g1,g2, . . . ,gn}. In the context of genomics, each node xi is a gene, and each gene
is associated with a logic function gi. The value of a gene is a binary variable, xi ∈ {0,1},
and is updated at the next time point t + 1 according to its associated function gi() and
the value of the genes (x1,x2, . . . ,xn) at the current time point t. The state of a gene xi
represents the expression of the gene, where xi = 1 indicates expressed, and xi = 0 indicates
not expressed. In the BN, all genes are assumed to updated synchronously, at each time
step.
In general, each function gi() depends on a subset of genes si ⊆ (x1,x2, . . . ,xn). In this
sense, this subset of genes determine or ”predict” the expression of a target gene xi. The
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subset of genes si is referred to as a predictor for gene i. In essence, a predictor describes
which genes directly interact with each other. The complete set of all predictors in the GRN
(for each of the genes in the GRN) is the predictor set. The complete set of functions for
each gene in the GRN in turn determine the complete dynamic behavior of the GRN. The
predictor set of the GRN determines the structure or topology of the GRN.
Naturally, the Boolean network describes a dynamic system. The expression values of
all the genes (x1,x2, . . . ,xn) at a particular time t is the state in the network at t. At the next
time point t +1, the network transitions to a new state as determined by the functions and
expressions of the genes at the current time step. For a BN with n genes, there are 2n total
states, and the behavior of the BN can be described in a state transition table (truth table)
or a state transition diagram. The long-term behavior of the BN is such that absent any
external input and given any starting state, the network repeatedly visits a fixed sequence
of state(s), forming a cycle. The states in such a cycle are called attractor states, while
the cycle is called an attractor cycle. Since the BN is deterministic, after it has reached an
attractor state, it will stay in the attractor cycle absent any external perturbation.
We present a small example of a Boolean network. In this example, there are 4 genes
(x1,x2,x3,x4) with the corresponding functions listed in Table I.1.
Gene Regulating Function
x1 g1 = (x3⊕ x4)
x2 g2 = x4
x3 g3 = (x1x2x4)
x4 g4 = x1 + x2 + x3
Table I.1. Boolean Regulating Functions for Example 4-Gene Network
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x4 x3
x2x1
Fig. I.6. Example BN topology (each node represents a gene)
From the functions in Table I.1, we can determine the topology (Figure I.6) and pre-
dictors of the BN. For example, the expression of gene x1 is predicted by genes x3 and x4.
Similarly, gene x2 is predicted by gene x4, and so on. The state space is [x1,x2,x3,x4] with
24 = 16 total states in the BN.
If at any time t, the BN has a state xt , then we can apply the gene regulating function
on xt (current state) to obtain xt+1 (next state). For example if the current state of the BN
is < x1,x2,x3,x4 >= 1010, then in the next time instant, xt+11 = (xt3 ⊕ xt4) = (1⊕ 0) = 1,
xt+12 = x
t
4 = 0 = 1, x
t+1
3 = (x
t
1x
t
2x
t
4) = (1 ·0 ·0)= 1, and x
t+1
4 = x
t
1+x
t
2+x
t
3 = 1+0+1 = 1.
In this way, by enumerating over all the values of < x1,x2,x3,x4 > in the state space, we
obtain < x1,x2,x3,x4 >t+1 and can populate the state transition table (Table I.2) and state
transition diagram (Figure I.7). From these we find the BN has two attractor cycles: a 3
state attractor cycle (1111)→ (0001)→ (1010) and a 1 state (singleton) attractor cycle
(0011)
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Current state Next state
x1 x2 x3 x4 x1 x2 x3 x4
0 0 0 0 0 1 1 0
0 0 0 1 1 0 1 0
0 0 1 0 1 1 1 1
0 0 1 1 0 0 1 1
0 1 0 0 0 1 1 1
0 1 0 1 1 0 1 1
0 1 1 0 1 1 1 1
0 1 1 1 0 0 1 1
1 0 0 0 0 1 1 1
1 0 0 1 1 0 1 1
1 0 1 0 1 1 1 1
1 0 1 1 0 0 1 1
1 1 0 0 0 1 1 1
1 1 0 1 1 0 0 1
1 1 1 0 1 1 1 1
1 1 1 1 0 0 0 1
Table I.2. Example 4-Gene State Transition Table
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1111
00011010
0000
0010 0110 1110
1101
0011
10010101110010000100
10110111
Fig. I.7. Example 4-gene state transition diagram
In logic-speak, the Boolean network introduced by Kauffman is equivalent to a Finite
State Machine (FSM). In an FSM, the machine can be in one state at a time (its current
state), which is stored in memory elements such as registers or flip-flops. The FSM can
change to another state (the next state), according to combinational logic function which
depends on its current state and inputs. These combinatorial logic functions are exemplified
by the gene regulating functions in Table I.1. Figure I.8 shows a block diagram of a typical
FSM. It can be seen that memory elements storing state at a particular time are the same
as the gene expression xti, and the combinational (next state) logic is the same as the gene
logic function gi, which operates on xt to produce xt+1i (i.e. gi(xt) = xt+1i ).
Similarly, the predictor of a gene is equivalent to the logical support of (gene regu-
lating) function. By modeling the GRN as a BN (FSM), this allows a rich set of logic
synthesis algorithms to be brought to bear to the problem of GRN inference and control.
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Next state
Memory
Logic
Combinational
OutputsInputs
Current state
Fig. I.8. Block diagram of finite state machine
I-D. Genomics Overview
Before introducing some key ideas in logic synthesis, we first present an overall view of ge-
nomics and its key issues. In genomics, an accurate representation of the GRN is necessary
for understanding how genetic diseases occur and how we can treat these diseases. Over the
lifetime of an organism, mutations can occur in the genome, causing changes in its normal
biological behavior. Mutations are caused several environmental factors (radiation, drugs,
etc.). Once a genome is mutated, the GRN behavior may deviate from that of a healthy
organism. Cancer and gene-related diseases are often the result of a failure in the gene sig-
naling mechanisms, leading to incorrect gene regulation and its associated functions. With
a GRN-based view of the biological functioning of the organism, we can potentially target
specific gene(s) for drugs, and hence modify their genetic expression, thereby treating the
disease. This is a promising way to treat genetic diseases, and can yield the possibility of
”personalized medicine” - targeted and specific disease prevention and treatment based on
an individual’s genetic information [20, 21].
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− gene expression
− pathways
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− custom drug
− clinical trials
TreatmentGRN
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Fig. I.9. Overview of genomics research areas
We can divide genomics into four main areas, biological observations, GRN inference,
GRN intervention, and treatment, as outlined in Figured I.9. Biological observations refer
to measurement of the GRN including gene expression measurements, pathways, sequenc-
ing, biopsy, and so on. GRN inference aims to infer a model of the GRN from observations
of the biological system, for example, inferring gene predictors or topology, or gene reg-
ulating function from binary valued or continuous gene expression measurements. The
GRN must describe both the topology and interaction of the genes in the network. The
topology refers to the connectivity structure of the genes (predictors and predictor set).
The interaction describes the dynamical behavior or regulating function of all genes. GRN
intervention analyzes the inferred GRN model to determine which genes can fail, leading
to disease, and how to intervene in the GRN to treat disease. Treatment applies the in-
tervention results to drive new drug development and direct clinical studies. The research
presented in this thesis focuses on GRN inference and GRN intervention.
The task of inferring a GRN is an arduous one. Because of the complex interaction
of the genes, it is hard if not impossible to construct a single biological experiment that
will yield the complete GRN. Instead, several steps are employed. First, from biological
measurements such as expression microarrays, biologists statistically observe that a certain
subset of genes G are involved in the growth and spread of a genetic disease. Multiple sam-
ples of the gene expression of the genes in G (for several diseased and healthy individuals)
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are taken for comparison. These can also be in the form of time course data (where expres-
sion of the genes in G are taken for the same individual, over a sufficiently long duration).
Time course data is generally not readily available, however. From the gene expression
data, logic techniques can be utilized to i) find the support or predictors for each gene
gi ∈ G, and ii) infer the function of the GRN. To validate the GRN obtained in this manner,
biologist can perform targeted experiments to verify specific gene interactions within the
GRN. Often, pathways (or portions) of the GRN are known, from targeted experiments that
have already been conducted by biologists in the past. By curating the results of several
such (often independently conducted) experiments, some GRNs have been inferred with
reasonable confidence. This information can be used to verify results, or used as additional
inputs to constrain the state space of our logic synthesis methods.
Once the GRN for a genetic disease is known, one main area of interest is to under-
stand how genetic disease arises from the GRN and how to intervene in the GRN to treat
diseases. In the case of genetic diseases, genes are mutated or damaged leading to signaling
failure in the GRN. The problem then becomes how to identify which genes are responsi-
ble for a particular disease and how to design drugs to correct the behavior of these genes.
If the specific effect of candidate drugs on particular genes is known, another problem of
interest is to find the best set of drugs which correct the GRN behavior of a diseased or-
ganism. Both problems can be cast as instances of another logic synthesis method called
automatic test pattern generation (ATPG).
I-E. Logic Synthesis
The Boolean Network [12] model for GRNs is a finite state machine (FSM), which pro-
vides the motivation for applying established and efficient techniques and algorithms from
the field of logic synthesis. In computer circuit design, logic synthesis is the process of
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converting a high-level specification into an optimized logic gate representation. Logic
synthesis techniques can be further split into methods, which include simplification of the
logic, mapping the logic to specific technology or libraries, timing optimization, and testing
or verification of the design. Logic synthesis is an essential step in the process of digital
integrated circuit (IC) design, given the ever increasing complexity of modern digital ICs.
For example, state of the art micro-processors comprise millions of gates, and their design
is made possible only with the help of computer-aided design (CAD) tools 1, which include
logic synthesis tools as well.
Logic synthesis techniques can take gene expression observations as inputs and infer
and construct the GRN as a Boolean network (logic circuit), which represents the gi(x)
functions of all the genes of the GRN. The resulting circuit can be simulated using logic
synthesis tools to query the long term behavior of the GRN and analyze its attractor cycles.
This thesis employs several logic synthesis techniques, all of which are based on Boolean
Satisfiability (SAT). While SAT is an NP-complete problem, many Boolean logic problems
translate naturally to SAT. Furthermore, SAT is heavily used in logic synthesis algorithms
and in the EDA industry, and as such there are many efficient SAT solvers that are available
for public download. In the remainder of this chapter, we first present an overview of logic
synthesis and SAT, and later describe the operation of SAT solvers.
I-E.1. Logic Functions and Representation
Definition I.1: Suppose that B = {0,1}. The Boolean n-cube Bn is a representation of the
n-dimensional hyperspace constructed by combining n instances of B.
Some examples of Boolean n-cubes are shown below and in Figure I.10.
1Computer-Aided Design (CAD) tools for IC design are also often referred to as Electronic
Design Automation (EDA) tools
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B1 = B = {0,1}
B2 = {0,1}X{0,1}= {00,01,10,11}
B3 = {0,1}X{0,1}X{0,1}= {000,001,010,011,100,101,110,111}
00 01
10 11
000
010 011
110 111
001
100 101
0 1
n = 3
n = 1
n = 2
Fig. I.10. Boolean n-cube Bn
Definition I.2: A Boolean function f is a mapping f (x1,x2, . . . ,xn) : Bn → B.
In other words, f maps each vertex of the Boolean n-cube (Bn) to 0 or 1.
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There are several types of representations for Boolean functions. Some common repre-
sentation used in logic synthesis include the Boolean n-cube (where each vertex is mapped
to a 0 or 1 value), the truth table, the Karnaugh map, and the Boolean formula.
Definition I.3: A truth table of a function f (x) : Bn → B is a table of the values of
each the 2n vertices of Bn. Each vertex of the Boolean n-cube appears in a row of the truth
table. The truth table comprises of columns (one for each input variable) and a column for
the output. The input columns of the the truth table represent the vertex of Bn. If the output
column is a ’1’, the row is referred to as a minterm, and if the output column is a ’0’, the
row is called a maxterm. An example of truth table for a 2-input (x,y) AND function is
shown in Table I.3, where only the vertex {1,1} is assigned to a ’1’, value and all other
vertices are assigned ’0’.
x y fAND
0 0 0 maxterm
0 1 0 maxterm
1 0 0 maxterm
1 1 1 minterm
Table I.3. Truth Table for AND Function fAND with 2 Input Variables
Definition I.4: A Karnaugh map (K-map) is a graphical representation of the truth
table of a function. In a K-map, each square represents a vertex v of Bn, and the contents
of any vertex is the value. An example of a K-map is shown in Figure I.11. The K-map in
this figure is that of the AND function with two input variables.
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0
1
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0
Fig. I.11. K-map for AND Function
Definition I.5: A literal or a literal function is a binary variable x or its negation x.
For example, x1,x2, . . . are variables, while x1,x1,x2,x2, . . . are literals.
Definition I.6: A cube or a product is a conjunction (AND) of literals. For example,
the cube xy is a conjunction of two literals x and y. In the example x1x2x3, this cube is a
conjunction of the literals x1, x2, and x3.
Definition I.7: A clause is a disjunction (logical OR) containing literals. For example,
(x1 + x3) is a clause with two literals x1 and x3. Another example is (x+ y+ z) which is a
clause with three literals x, y, and z.
Definition I.8: A Sum of Products (SOP) expression is a canonical representation of
a function f , which consists of a disjunction (OR) of minterms. For example, the SOP of a
2-input AND gate is fAND = xy.
Definition I.9: A Product of Sums (POS) expression is a canonical representation of
a function f , which consists of a conjunction (AND) of maxterms. The POS is the dual of
the SOP. For example, the POS of a 2-input AND gate is fAND = (x+ y) · (x+ y) · (x+ y).
Definition I.10: A Conjunctive Normal Form (CNF) expression S consists of a con-
junction (AND) of m clauses c1 . . .cm. Each clause ci consists of disjunction (OR) of ki
literals. POS is a form of CNF.
Definition I.11: A Boolean formula is a formula that represents a function. The
formula is defined as catenations of:
• parentheses ( )
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• literals (x,y,x,y)
• Boolean operators (”+”) OR, (”·”) AND
• complementation (example: x+ y)
Following are three examples of Boolean formulas.
f = x1 · x2 + x1 + x2
g = (x1 + x2) · (x1 + x2)
h = a · (b+ c)
Often, the AND operator ”·” is replaced by catenation, for example a ·b is replaced by
ab.
For any Boolean function, there are an infinite number of Boolean formulas. Note
that in the previous examples of Boolean formulae above, both f and g are formulas that
represent the same Boolean function. The goal of logic synthesis is to find the ”best”
Boolean formula for a function. In chip design, the utility function for logic synthesis may
include minimizing number of gates (which may be selected from a standard gate (or cell)
library) or minimizing the estimated circuit’s delay or power.
I-E.2. Boolean Satisfiability
Boolean satisfiability (SAT) is an NP-complete decision problem. Given a Boolean formula
in CNF form, SAT determines if there is an assignment of the variables that will satisfy the
formula (make the formula evaluate true). Many algorithms in logic synthesis and elec-
tronic design automation (EDA) can be cast as an instance of Boolean satisfiability. Some
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examples where SAT is used in logic synthesis and EDA include functional equivalence
checking, automatic test pattern generation (ATPG), and logic optimization. In addition,
the industry and research community have developed several efficient and scalable SAT
engines. In this thesis, we take advantage of these advancements in SAT solvers, and apply
them towards problems in genomics. We first define basic terms in Boolean satisfiability.
Definition I.12: Boolean satisfiability (SAT). Given a Boolean formula S (on a set of
binary variables X ) expressed in CNF, the objective of SAT is to identify an assignment of
the binary variables in X that satisfies S, if such an assignment exists. If no such assignment
exists, S is concluded to be unsatisfiable (UNSAT).
In order to satisfy the formula S (i.e. make it evaluate to true), each clause of S must
have at least one literal evaluate to true. Satisfying S is equivalent to satisfying all ci ∈ S.
In general, there may exist many satisfying assignments for the formula in question.
For example, consider the formula:
S(a,b,c) = (a+b) · (a+b+ c)
This formula consists of 3 variables, 2 clauses, and 5 literals. To determine if the
formula is satisfiable, we attempt to satisfy all the individual clauses. If all clauses are
satisfied, then the formula S is also satisfied. We observe that the first clause (a+ b) is
satisfied (or evaluates to 1) if either a = 0 or b = 0. In that case, a = 1 or b = 1 respectively,
which satisfies the first clause. If a = 0 and b = 0, the second clause (a+b+c) is satisfied
only if c = 1.
Because all its clauses are satisfied, we conclude that S is satisfiable, and a satisfying
assignment is (a,b,c) = (0,0,1) or abc. Note, the cube (product) abc is logically the same
as stating that a = 0,b = 0, and c = 1.
An extension of the SAT problem, in which the goal is to find all satisfying assign-
ments is called All-SAT.
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Definition I.13: All-SAT. Given a Boolean formula S (on a set of binary variables X )
expressed in CNF, the objective of All-SAT is to find all assignments of the binary variables
in X that satisfies S, if such an assignment exists.
One simple algorithm for All-SAT is to perform SAT on the formula S, express the
satisfying assignment as a cube k, complement k to get a clause c, add c as a new clause of
the formula S, and perform SAT again repeatedly until an UNSAT result is obtained. The
inclusion of c in S ensures that the same cube k cannot be found as a satisfying assignment
again. The process continues until no new solutions can be found.
To demonstrate All-SAT, we refer back to the previous example, S(a,b,c) = (a+b) ·
(a+ b+ c) where we found a satisfying cube k = abc. We perform an All-SAT by first
taking the satisfying cube and complementing it (using DeMorgan’s law) to form a new
clause c to be added to S:
c = k = (abc) = (a+b+ c)
The new clause c is then appended to the original formula to obtain S = S · c:
S = (a+b) · (a+b+ c) · (a+b+ c)
Note that the new clause c is unsatisfiable using the variables from k, ensuring that
the next iteration of SAT will find a different satisfying cube. The new CNF S is solved by
SAT again to obtain a new satisfying cube, for example abc. The steps are repeated until
no new satisfying assignments are found.
Another useful extension of SAT is Weighted partial Max-SAT (WPMS) which aims
to satisfy a subset of the clauses. In WPMS, each clause in the CNF is identified as a hard
clause or soft clause. Each soft clause is associated with a weight. The problem then is to
identify an assignment that satisfies all hard clauses while maximizing the total weight of
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the satisfied soft clauses.
Definition I.14: Weighted partial Max-SAT (WPMS). Given a Boolean formula S
(on a set of binary variables X ) expressed in CNF, where each clause is identified hard
clause or soft clause , the objective of WPMS is to identify an assignment of the binary
variables in X that satisfies all hard clauses in S and maximizes the total weigh of all
satisfied soft clauses, if such an assignment exists.
To give an example of WPMS, consider the following CNF:
S(x,y,z) = (x+ y) · (x+ z) · (y+ z) · (x) · (y) · (z)
In this CNF, we are given that the first three clauses (x+ y),(x+ z),(y+ z) are hard
clauses, while the last three clauses are soft clauses (x),(y),(z). Furthermore, the soft
clauses (x),(y),(z) are assigned weights of 3, 7, and 6 respectively.
For WPMS, an assignment of (x,y,z) must satisfy all the hard clauses and maximize
the total weight of the satisfied soft clauses. In this example, each soft clause contains a
single positive literal, and to satisfy any one of the soft clauses, its corresponding variable
needs to be set to its positive literal. However, no more than one of the three variables can
be assigned to their postive litera, while the other two variables must be assigned to their
negative literals in order to satisfy the hard clauses. Of the soft clauses, (y) has the highest
weight, so the satisfying solution with maximum weight is (x,y,z) = (0,1,0) or xyz, with
weight = 7.
I-E.3. SAT Solvers
While several high-performance algorithms exist for solving SAT, the most popular in logic
synthesis and electronic design are conflict driven methods based on the Davis-Putnam-
Logemann-Loveland or DPLL algorithm [22].
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The DPLL algorithm is a complete2 search process for finding a satisfying assignment
by implicitly pruning of the exponentially sized search space. This algorithm searches for
a satisfying assignment through repeated branching and decision steps. In the branching
step, an unassigned variable x is selected in the CNF formula S. The decision step sets x
to 1 or 0, resulting in the CNF formulas Sx (which is S with x replaced by 1) or Sx (which
is S, with x replaced by 0). The branching and decision steps are recursively repeated for
all remaining unassigned variables in S until a solution is found, or the search space is
exhausted.
The DPLL algorithm performs a depth first traversal of the state space. During the
search, a partial variable assignment list p is recorded. If Sp contains an empty clause (0),
for example Sp = (. . .) ·(0) ·(. . .), then Sp is unsatisfiable. In this case, the DPLL algorithm
backtracks and then branches or decides on a different variable or value. If all variables
have been assigned in p and there are no empty clauses in Sp, then S is satisfiable and p is
the satisfying assignment.
For example, consider the CNF formula S(a,b,c) = (a+ b) · (a+ b+ c), where the
variable a is the first to be selected for branching. Also, let us assume that a is set to its
negative literal (a replaced by 0), and the assignment list is updated to p = a. We evaluate
Sa by setting a = 0 and simplifying the formula. We recall that a clause with a literal
evaluating to 1 means the clause is satisfied, and can be removed from the CNF.
S = (a+b) · (a+b+ c)
Sa = (0+b) · (0+b+ c) = (b+ c)
We continue the example by selecting variable b as the next variable for branching.
2A complete or exact algorithm is one that is guaranteed to find a solution if a solution exists.
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Let us assume that b is set to its negative literal, and the assignment list is updated to p= ab.
We evaluate Sab by setting b = 0 and simplifying the formula.
Sab = (0+ c) = (c)
The last variable c is selected. Again, let us assume that c is set to its negative literal,
and p = abc. We evaluate Sabc.
Sabc = (0)
In this case, the partial assignment p = abc causes the formula evaluates to 0, and the
DPLL algorithm backtracks. Let us assume that the algorithm now sets c to its positive
literal (c = 1) and partial assignment is updated to p = abc. We evaluate Sabc.
Sabc = (1)
At this point, all clauses have been satisfied and all variables have been assigned. We
conclude that S is satisfiable and p = abc is a satisfying assignment.
Modern SAT solvers [23, 24, 25, 26] augment DPLL with techniques such as variable
selection heuristics, clause learning, and watched literals to greatly improve SAT solving
efficiency. In the following, we briefly describe each of these techniques.
Variable selection heuristics vary widely between SAT solvers. The next variable
to branch on has a key role to play in determining solver efficiency. Common strategies
include random selection of a variable, maximum occurrence of variable in clauses of min-
imum size, most frequent variable in unsatisfied clauses, or choose variables based on
weights from conflicts.
Watched literals [25] is an efficient method to identify variables for assignment that
are required to satisfy Si. For example, if a clause consists of one unassigned literal and
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all other literals are set to 0 value, then the unassigned literal must be set to 1 value for
the clause to be satisfied. In this situation, the unassigned variable set to 1 value is an
implication. Any time a decision (variable branch or value set) is made in DPLL, this
generates new implications.
In [25], the method selects (watches) two literals for each clause not yet satisfied in the
partial assignment. The watched literals can be set to 1 or unassigned. With this method,
satisfiability of a clause can be tested by checking whether one of the watched literals is 1,
significantly reducing computation and memory requirements for SAT solving. So long as
both watched variables are not set to 0 value, the clause is not implied.
For example, during the DPLL process if a variable x is set 0, all clauses with watched
literal x must find another literal to watch as this implies that the other watched literal must
be set to 1 to be satisfied. Furthermore, for any clauses that are satisfied when x = 0, x
is set as a watched literal. If no other literals are available to watch, the algorithm must
backtrack, and the results of which can be used in clause learning.
Clause learning [25, 26] is a technique which improves efficiency of DPLL by avoid-
ing redundant computation on assignments that are unsatisfiable. The technique keeps
tracks of clauses that become empty, causing a conflict in the algorithm. The CNF leading
to a conflict is analyzed through its structure and implications to create a conflict clause to
learn. The DPLL algorithm then backtracks and the conflict clause is included in the CNF.
In [26], each decision in the DPLL algorithm is recorded with the time (or time step)
of the decision. For example, variable x1 was set to 1 value at time 6, or variable x9 was
set to 0 value at time 1. All decisions up to the current assignment can be shown on an
implication graph, for example Figure I.12.
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conflict
c=1 @ 6
b=1 @ 6
d=1 @ 6a=1 @ 6
i=0 @ 1 k=0 @ 3
K
Fig. I.12. Implication graph for current assignment
When a conflict occurs at a decision K, the conflicting assignment A can be determined
by traversing the graph backwards from K. Only the assignments at previous assignments
of K are a sufficient condition for the conflict. For example, from Figure I.12, the conflict-
ing assignment is A = {a = 1@6, i = 0@1,k = 0@3}. The conflict assignment induces the
conflict clause C = (aik). The conflicting assignment and induced conflict clause enables
further implications which improves the search and backtracking in the SAT solver engine.
I-F. Chapter Summary
As we deepen our understanding of how cells operate and how genetic diseases occur, we
realize that many cell components are involved in cell function and that a systems engi-
neering approach is required. In this chapter, we described the key issues in genomics and
provided an introductory background to the genome and gene regulatory network. Our
work proposes to model the GRN as a Boolean network (FSM), from which we can use
logic synthesis techniques and Boolean Satisfiability to tackle several genomics problems.
We take advantage of improvements in modern SAT solvers to provide efficient and pow-
erful tools for research. The following chapters present our methods and application to
biological networks. In Chapter II, we present a method for inferring the gene predictor
set [27, 28] from gene expression data. Following in Chapter III, we use the predictor set
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and gene expression data to determine gene function [29] to define a family of BNs. Chap-
ter IV presents a method for inferring and ranking gene predictors from continuous gene
expression data using modified Zhegalkin functions. Lastly, in Chapter V, we use ATPG
techniques on the BN [30, 31] to identify genes leading to cancer and to determine drug
selection for cancer therapy.
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CHAPTER II
PREDICTOR SET INFERENCE USING SAT
The inference of gene predictors in the gene regulatory network (GRN) has become an
important research area in the genomics and medical disciplines. Accurate predictors are
necessary for constructing the GRN model and to enable targeted biological experiments
that attempt to validate or control the regulation process. In this chapter, we implement a
SAT-based algorithm to determine the gene predictor set from steady state gene expression
data (attractor states). Using the attractor states as input, the states are ordered into attrac-
tor cycles. For each attractor cycle ordering, all possible predictors are enumerated and
a conjunctive normal form (CNF) expression is generated which encodes these predictors
and their biological constraints. Each CNF is solved using a SAT solver to find candidate
predictor sets. Statistical analysis of the resulting predictor sets selects the most likely
predictor set of the GRN, corresponding to the attractor data. We demonstrate our algo-
rithm [27, 28] on attractor state data from a melanoma study [32] and present our predictor
set results.
1
II-A. Background
With increasing availability of gene expression data, the focus in computational biology
has shifted to the understanding of gene regulation and its inter-relation with the biological
system. The use of genome information has given rise to the possibility of ”personalized
medicine” – targeted and specific disease prevention and treatment based on individual gene
information [20, 21]. The urgent applications to cancer and gene-related diseases calls for
1Part of the data reported in this chapter is reprinted with permission from ”Inference of
Gene Predictor Set Using Boolean Satisfiability” by Pey-Chang Kent Lin, Sunil P. Khatri.
IEEE International Workshop on Genomic Signal Processing and Statistics (GENSIPS)
2010, Nov. 2010, pp. 1-4, Copyright 2010 by IEEE
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the genomics field to significantly improve the algorithms used for accurate inference of
the gene regulatory network (GRN).
In an organism, the genome is a highly complex control system wherein proteins and
RNA produced by genes and their products interact with and regulate the activity of other
genes [33]. A predictor for a target gene gi is the collection of genes directly participating
in the regulation of gene gi. As such, the predictor does not consider the type of regulation
(repression versus activation), and is analogous to the support of a function in logic syn-
thesis. Each gene has a single predictor (which is a collection of genes) and the predictor
set is the set consisting of predictors of each gene in the GRN.
There are several observations that impact the formulation of our GRN model and
predictor inference algorithm. First, the activity level (i.e. activation or repression) of
all genes at a particular time t represents the state of the GRN at that time t. From our
knowledge of biological systems, we observe that over time, cellular processes converge
to sequences of stable attractor states. Some of these attractor states represent normal
cellular phenomena in biology (i.e. cell cycle and division), while other attractor states
are consistent with disease (i.e. metastasis of cancer). Second, the GRN is often inferred
by observing microarray-based experimental data though which the activity level of genes
is measured. Both observations of gene activity (or state) can be used to infer the gene
regulation network. The disadvantage of using microarray data is that such studies do not
involve controlled time-series experimental data. Hence the measurements are assumed to
arise from cyclic sequences of gene expressions (attractor states) in steady state. Such a
sequence is referred to as an attractor cycle. The GRN is then inferred from this data, using
methods traditionally based on probabilistic transition models [34, 35].
As previously mentioned, it is necessary to determine the predictor set in order to
reconstruct the GRN. However, there may exist many possible predictors for any gene,
based on the attractor cycle data. Furthermore, only certain combinations of predictors may
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form a valid predictor set, due to biological constraints. The issue addressed in this paper is
how to efficiently and deterministically select the predictors that form the predictor set. We
have implemented a Boolean satisfiability (SAT) based algorithm for the inference of gene
predictor sets. Satisfiability is a decision problem of determining whether the variables in
a Boolean formula (expressed in Conjunctive Normal Form or CNF) can be assigned to
make the formula evaluate to true. Although SAT is NP-complete, many SAT solvers have
been developed to quickly and efficiently solve large SAT problems. Our algorithm takes
advantage of a recent SAT solver to find the predictor set.
The basic outline of our SAT-based algorithm for predictor set inference is described
briefly below. First, all possible orderings of attractor states are enumerated, yielding all
possible attractor cycles. For each ordering, we enumerate all predictors that are logically
valid, and create a CNF expression which encodes all these predictors and biological con-
straints (such as cardinality bounds on the predictors). A SAT solver is then used to find the
valid candidate predictor sets. After this process is done iteratively for all attractor cycle
(orderings), statistical analysis provides the most likely predictor set. Note that this paper
does not claim to extract the GRN. Using the predictor set inferred by this paper, we plan
to infer the GRN in a subsequent research effort.
The key contributions of this chapter are:
• We develop a Boolean Satisfiability based approach to realize the gene predictor set
from attractor state data.
• We modify an existing SAT-solver (MiniSat [23]) for efficient all-SAT computation,
and further optimize the decision engine of MiniSat for improved predictor set infer-
ence.
• On gene expression data from a melanoma study [32], we apply our SAT-based al-
gorithm and present the predictor set, including the predictor for the cancer gene
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WNT5a.
• Our approach can be used to find the predictor set for any gene related disease, pro-
vided attractor state data is available. The predictor set information obtained from our
algorithm can be used by biologists to fine tune their gene expression experiments.
II-B. Previous Work
In the context of predictor set inference, [36, 37] use dynamic Bayesian networks and
probabilistic Boolean networks (PBNs). The GRN is then inferred from this data, using
methods traditionally based on probabilistic transition models [34, 35] The method pro-
posed considers gene prediction using multinomial probit regression with Bayesian vari-
able selection. Genes are selected which satisfy multiple regression equations, of which
the strongest genes are used to construct the predictor set. The target gene is predicted
based on the strongest genes, using the coefficient of determination to measure predictor
accuracy.
Another method proposed by [38] also assumes a PBN model. A partial state transi-
tion table is constructed based on available attractor state data. From this state transition
table, predictors with 3 or less regulating genes are selected for each target gene. All un-
known values in the table are randomly set. The Boolean network is simulated for several
iterations using different starting states, observing whether the states eventually transition
to an attractor cycle. If the simulation successfully transitions to an attractor cycle, the
selected predictors are considered as a valid predictor set. This process is repeated, to build
a collection of Boolean Networks which are combined to form a Probabilistic Boolean
Network (PBN).
Our larger goal is to find a small number of deterministic GRNs, rather than a PBN.
Towards this, we need to first find ways to accurately find the predictor set. This is the
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focus of this chapter. Philosophically, our aim is to invest effort into accurate predictor set
determination, so that the results can be used to find high quality deterministic GRNs.
II-C. Background
This section describes our background and problem definition for inference of predictor sets
using SAT. We begin with some GRN definitions and then explain some of the biological
constraints that will be used in our formation for the the next section.
Definition II.1: A predictor fi = {g j,gk, · · ·} lists the set {g j,gk, · · ·} of genes which
regulate the activity of gene gi.
Definition II.2: The predictor set is the complete set of predictors { f1, f2, · · · , fn} for
the GRN with n genes g1,g2, · · · ,gn.
Based on the gene products of one or more genes in a set fi, a gene gi can become
repressed or activated. in this case fi is said to be predictor of gene gi. A predictor for
target gene gi is the collection of genes directly participating in the regulation of gene gi.
As such, the predictor does not consider the type of regulation. Each gene has a single
predictor and the predictor set is the set consisting of predictors of each gene.
Note, we can relate these terms to logic synthesis: the predictor is identical to the
logical support of a logic node, while the predictor set is akin to the circuit netlist. The
Boolean network GRN then is the complete logic circuit including function for each node.
Definition II.3: Given a starting state, within a finite number of steps, the network will
transition as determined by the gene functions into a cycle of states, called an attractor
cycle. States in an attractor cycle are called attractor states. The attractor cycle repre-
sents the long term behavior of the network and absent perturbation, a network that has
transitioned to an attractor will continue to cycle thereafter.
There are several observations that impact the formulation of our GRN model and
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predictor inference algorithm. First, the activity level (i.e. activation or repression) of
all genes at a particular time t represents the state of the GRN at that time t. From our
knowledge of biological systems, we observe that over time, cellular processes converge
to sequences of stable attractor states. Some of these attractor states represent normal
cellular phenomena in biology (i.e. cell cycle and division), while other attractor states are
consistent with disease (i.e. metastasis of cancer).
Second, the GRN is often inferred by observing microarray-based experimental data
though which the activity level of genes is measured. Both observations of gene activity
(or state) can be used to infer the gene regulation network. The disadvantage of using
microarray data is that such studies do not involve controlled time-series experimental data.
Hence the measurements are assumed to arise from cyclic sequences of gene expressions
(attractor states) in steady state. Such a sequence is referred to as an attractor cycle.
II-D. Problem Formulation and SAT Construction
Given gene expression data (a set of unordered attractor states) as input, we would like to
determine the best predictor set. We first present an outline of our SAT-based algorithm,
and then explain the steps through a simple example.
The algorithm has three main steps.
1. SAT Construction for Predictor Set: In this step, attractor states are ordered into
attractor cycles in all possible ways. For each possible ordering of attractor states into
attractor cycles, all possible predictors are found and a CNF is generated encoding
valid predictor sets.
2. All-SAT: Each attractor ordering from step 1 generates a CNF which is solved for
All-SAT. All satisfying cubes are recorded, where each satisfying cube corresponds
to a predictor set. The first two steps are repeated for all attractor cycle orderings.
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3. Predictor Set Selection: Statistical analysis on the All-SAT results determines the
most frequent (likely) predictor set for the GRN. This step is explained in Section II-
E.
To illustrate the SAT-based algorithm, we apply it to a simple example with three genes
(g1,g2,g3) and gene expression data with three lines (010,110,111). The present state of
these genes is represented by the variables < x1,x2,x3 > and the next state is represented
by the variables < y1,y2,y3 >. We assume each line was measured in steady state and
therefore is an attractor state.
We order (or arrange) the attractor states into attractor cycles for which there are six
possibilities for our example. One ordering is with each attractor state transitioning to itself
with a self-edge, resulting in three singleton attractor cycles. Two possible orderings result
when all three attractor states form a single attractor cycle of length three. The last three
possible orderings have two attractor cycles, one cycle with length two and the other cycle
of length one. We focus our example on an ordering with two attractor cycles, as shown in
Table II.1.
II-D.1. Partial State Transition Table
For each valid attractor cycle ordering, a partial state transition table is constructed, con-
taining the attractor states. Table II.1 shows the partial state transition table for the example
attractor cycle ordering. To find all valid predictors of a gene, each next state column is
checked against all combinations of the current (present) state columns. For example, let
us explore gene g2 and g3 as a predictor for gene g1. For gene g1, the next state bit is y1,
while for gene g2 and g3, the current (present) state bits are x2 and x3. In the first two rows
of TableII.1, < x2,x3 >= 10. However, in row 1, y1 = 1, while in row 2, y1 = 0, which
forms a contradiction (since the same input cannot result in different outputs). Therefore,
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gene g1 cannot be predicted by genes g2 and g3.
Now, consider genes g1 and g3 as a predictor for gene g1. There is no contradiction,
and the combination is logically valid. Thus one possible predictor for gene g1 is f1 =
{x1,x3}. All valid predictors with P (user-defined) or less inputs are exhaustively searched
and recorded for CNF formulation (which is done in the next step). In our example, gene
g1 has 2 possible predictors {x1,x3}, {x1,x2,x3} which we label v11,v12 respectively. We
assume that a gene cannot self-regulate, so {x1} by itself is not a valid predictor.
Current state Next state
x1 x2 x3 y1 y2 y3
0 1 0 1 1 0
1 1 0 0 1 0
1 1 1 1 1 1
Table II.1. Example 3-Gene Partial State Transition Table
II-D.2. SAT Formulation and GRN Constraints
After all predictors are found for each gene, we generate the SAT formula which en-
codes logically valid predictor sets. The jth predictor for gene i is assigned a variable vij.
Gene g1 in our example will have two predictor variables v11 ≡ {x1,x3}, v12 ≡ {x1,x2,x3}.
Gene g2 and g3 will have their own corresponding predictor variables v21 ≡ {x1,x2}, v22 ≡
{x1,x3}, v23 ≡ {x2,x3}, v
2
4 ≡ {x1,x2,x3} and v31 ≡ {x1,x3}, v32 ≡ {x2,x3}, v33 ≡ {x1,x2,x3}
respectively. There are three constraints that we incorporate while constructing the CNF
that encodes valid predictor sets. The conjunction of these constraints forms our final CNF.
1. The first constraint (S1) is that all genes in the GRN must have a predictor. In other
words, we assume that all genes are highly correlated and are ”participating” in the
GRN. For gene i, all of its associated predictor variables are written in a single clause
38
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In our example, for g1, c11 = (v11+v12). For g2 and g3, we have c12 = (v21+v22+v23+v24)
and c13 = (v31 + v32 + v33) respectively.
To satisfy any c1i clause, at least one predictor in the clause must be chosen. To ensure
that at least one predictor is chosen for all genes, we write the conjunction of all c1i
clauses as S1 (Equation 2.1).
S1 = c11 · c12 · c13 (2.1)
2. The second constraint (S2) specifies that for each gene, exactly one predictor is cho-
sen. The assumption is that a gene cannot have multiple predictors. To formulate
the clauses c2i for gene i, smaller clauses are formed from all pairs of combinations
of its predictors vi1··· j. In each of these clauses of pairs of variables, both predictor
variables are complemented.
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Any selection of two or more predictors for gene i will result in the clauses of c2i
becoming unsatisfiable. The c1i clause ensures that at least one predictor will be
chosen for gene i, and c2i forces the selection of exactly one predictor for gene i. The
conjunction of all c2i clauses forms the constraint S2 (Equation 2.2), which forces
SAT to choose only one predictor per gene.
S2 = c21 · c22 · c23 (2.2)
3. The last constraint (S3) requires that each gene must be used as a predictor for at
least one other gene in the predictor set. A gene that is not used in any predictor does
not perform any regulation function and could be removed from the GRN. S3 ensures
that this does not occur. To ensure that gene gi is used in at least one predictor, we
form clauses c3i which include all predictors that use gene gi as input. To specify that
gene gi must be used, we also include a single variable clause (xi) to c3i . For gene g1,
g2, and g3, we create the following clauses c31, c32, and c313 respectively:
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To satisfy these clauses, xi and at least one other predictor variable in the second
clause of c3i must be selected. S3 is a conjunction of all the c3 clauses (Equation 2.3).
S3 = c31 · c32 · c33 (2.3)
The final SAT formula S as a conjunction of the Si formulas (Equation 2.4).
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S = S1 ·S2 ·S3 (2.4)
II-D.3. All-SAT
The SAT solver performs an All-SAT on S. The satisfying cubes (each cube encodes a
candidate predictor set) from the All-SAT output are collected. The process is repeated for
the remaining attractor cycle orderings. From the results, we find the most likely predictors
based on the frequency of occurrence of the predictors across all orderings. Three methods
are used to analyze the statistical results, which will be described in the next section.
In general, the above algorithm can be applied to input data for N genes and A attractor
states. The total number of attractor state orderings is A!. For each ordering, there can
be up to O(N3) predictors per gene. The SAT search space per ordering is on the order
of O(2N3), resulting in overall complexity of O(A!2N3). Typically, the number of attractor
states A recorded through gene expression measurements is small. As such, A! is thus much
smaller than 2(N3), so the runtime complexity is dominated by the All-SAT operation. For
pragmatic reasons, our algorithm stops each All-SAT after T minutes (or C cubes), where
T or C is defined by the user.
II-E. Experimental Results
To evaluate our SAT-based algorithm for inferring gene predictors, the algorithm was tested
on gene-expression data from a melanoma study done by Bittner and Weeraratna [32]. In
the melanoma study, it was observed that an abundance of RNA (expression) for gene
WNT 5A was associated with a high metastasis of melanoma. The study measured 587
genes with 31 gene expression patterns (lines). Seven genes are believed to be closely
knit: PIRIN,S100P,RET1,MART1,HADHB,STC2, and W NT 5A. There are 18 distinct
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patterns, which were reduced to seven using Hamming-distance of one, in Table II.2. These
seven lines form the attractor states which are the input to our algorithm.
PIRIN S100P RET 1 MART 1 HADHB STC2 W NT 5A
x1 x2 x3 x4 x5 x6 x7
BAD 0 0 0 0 0 1 1
0 0 1 1 1 1 1
1 0 1 0 0 0 1
GOOD 0 1 0 0 0 0 0
0 1 1 1 0 0 0
1 0 1 1 1 1 0
1 1 0 1 1 0 0
Table II.2. Attractors for Melanoma Network
For the experiments, we assume two additional specifications. First, we divide at-
tractor states into good and bad states, based on the presence of WNT 5A. We allow good
attractor states to cycle only to other good attractor states, and bad attractor states can only
cycle to other bad attractor states. Second, we limit the maximum attractor cycle length
L to 3, and the maximum number of predictor inputs P to 3, because long attractor cy-
cles and large predictor inputs are highly complex and less likely to occur in biological
systems [39, 33].
Our algorithm utilizes a modified open-source and highly efficient exact SAT-solver
called MiniSAT v1.14 [40, 23]. All-SAT operations were limited to a 30 minute time-out.
On average, each All-SAT run yielded 10K satisfying cubes in this duration. Our algorithm
was implemented and run on a Pentium 4 Linux machine with 4GB RAM. MiniSat [23],
was originally designed to find a single satisfying assignment. We modified MiniSat to
perform All-SAT as MiniSat normally only returns one SAT result. We further modified
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MiniSat to always randomly select decision variables during the solving process to increase
the activity of all variables.
The unaltered MiniSAT uses a heuristic for selecting the next decision variables. How-
ever, this heuristic results in many of the same variables being chosen over iterative runs of
MiniSat. To increase the activity of all variables, we change the random variable frequency
of MiniSat to 100% (from 2% in the unaltered MiniSat code). This forces MiniSAT to
always choose a random variable on every variable-branch decision. A random variable
frequency of f % means that MiniSat selects the next variable randomly f % of the time.
Fig. II.1. Average predictor error difference on melanoma attractor data using MiniSat with-
out modification
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Fig. II.2. Average predictor error difference on melanoma attractor data using MiniSat with
random variable selection modification
To validate the quality of predictor selection using our modified All-SAT, our algo-
rithm was run on four selected attractor cycle orderings (labeled 10, 721, 744, and 849)
using melanoma data from [32]. The All-SAT operation was allowed to run for 12 hours
(which approximates a complete All-SAT). In the case of attractor cycle order 721, all
cubes were found. In Figures II.2 and II.1, we compare the average difference in all the
predictors’ occurrence frequency in the complete All-SAT result with the results obtained
with shorter All-SAT runtimes (10, 30, 60, and 120 minutes). Figure II.2 shows the av-
erage error difference of all predictors’ frequency for the four orderings, using MiniSat
with the random variable selection modification (100% random variable frequency), while
Figure II.1 shows the same results without random variable selection (2% random variable
frequency). Across the four orderings analyzed, the average error difference of all predic-
tors’ occurrence frequency (shown in Figures II.2 and II.1) is significantly lower using the
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random variable selection modification than without. Furthermore, the average error differ-
ence decreases with increasing runtime when using random variable selection. From this
experiment, we determine that 30 minutes with random variable selection was sufficient to
achieve an average of ≤ 5% difference in the predictors’ occurrence frequency compared
to the full All-SAT results.
The following presents our results after collection of All-SAT results from all valid
attractor cycle orderings. In Figure II.3, we display a histogram of all logically valid pre-
dictors and their frequency of occurrence, across all attractor orderings. In the sequel, a
predictor label of 2367 means that gene g2 is predicted by genes g3,g6, and g7. From this
chart, we can observe that certain predictors occur with significantly higher frequency than
others. For example with gene g1, the predictor {x3,x5,x7} (PIRIN predicted by RET 1,
HADHB, WNT 5A) occurs with much higher frequency than all other predictors for gene
g1. This indicates that this predictor is most likely to be present in the final predictor set.
From this data, we propose three methods (A, B, AB) for selecting the predictor set.
II-E.1. Method A
In method A, a predictor histogram is created as in Figure II.3. From the histogram, for
each gene gi, we find its predictor pij such that pij is the most frequently occurring predictor
of gene gi and the resolution ratio Ri of this predictor (defined as the ratio of the occurrence
frequency of pij to the occurrence frequency of the next most frequently occurring predictor
of gene gi) is maximum. Among all genes, we choose the one with the highest resolution
ratio, and select its most frequently occurring predictor as its final predictor. After selecting
this final predictor, we regenerate the histogram, discarding any candidate predictor sets
that do not contain the final predictor(s) that have been selected in previous steps. The
process repeats until all genes have a single final predictor. The set of final predictors of
all genes forms the predictor set. The advantage of method A is that at every iteration,
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we select real predictors that have a high overall occurrence in the solution. However the
method may have problems selecting final predictors if the resolution ratio is low (i.e. when
the frequencies of occurrence of the predictors are nearly identical).
Fig. II.3. Method A: Predictor occurrence for all valid attractor cycle orderings (first itera-
tion: no predictor selected)
II-E.2. Method B
As an alternative, method B is proposed, to determine for each gene i, how likely it is
that gene gi will predict the other genes in the GRN. In other words, we ask what is the
occurrence frequency of xi in the predictors of f j. Table II.3 shows in entry (i, j) how
frequently a gene gi is used to predict a gene g j. This table is populated by summing
the occurrence frequency of all predictors of g j that have gene gi as one of their inputs.
As such, any entry can be ≥1, and is a measure of the usefulness of gi as a predictor for
g j. The predictor of g j is determined by finding, for each column j of Table II.3, the
three largest entries and adding their values. Suppose we call this sum s j (the resolution
score of column j). We compute the resolution score for all columns and select the final
predictor for the column with the highest resolution score. This final predictor is formed
by listing the 3 input genes that correspond to the 3 entries that were used to compute the
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highest resolution score. Similar to method A, we reiterate the process by regenerating the
table after discarding all predictor sets that do not contain predictors that were selected in
previous steps. Method B has the advantage of being more robust when no single predictor
has a significantly higher occurrence frequency than others. However, there is no guarantee
that the predictor selected by method B is a valid predictor. If this happens, we select the
column with the next highest resolution score.
f1 f2 f3 f4 f5 f6 f7
x1 0.59 0.68 0.57 0.69 0.60 1.00
x2 0.24 0.41 0.29 0.33 0.49 0.51
x3 0.65 0.48 0.76 0.58 0.56 0.17
x4 0.39 0.40 0.78 0.54 0.44 0.29
x5 0.56 0.30 0.27 0.44 0.39 0.36
x6 0.42 0.54 0.52 0.41 0.44 0.67
x7 0.64 0.63 0.24 0.48 0.32 0.45
Table II.3. Method B: Gene Occurrence for All Predictors (First Iteration)
II-E.3. Method AB
In our experiments, we also use a hybrid method AB which works in the following man-
ner. Both methods A and B are used to select their best predictor. If both methods produce
the same predictor fi, we select this predictor as a final predictor. If not, we list the best
predictors for each gene, for both methods. If multiple predictors match for both methods,
we choose the final predictor as the one with the highest weighted sum of the resolution
ratio and resolution score. The resolution ratio is weighted by 0.3 and the resolution score
is weighted by 0.7. The weighting factor for the resolution ratio is lower since the reso-
lution ratio values of any gene are often close to 1. In such a situation, we would like to
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favor method B. If no predictor is produced by the previous step, we look at the top five
predictors of method A for each gene and calculate the weighted sum of their resolution
ratio and resolution score. The predictor with the highest weighted sum is selected as the
final predictor. The process is reiterated, regenerating the histogram and table at each step,
discarding any predictor sets that do not contain any of the previously selected final predic-
tors. With this combined approach, we are able to select predictors with a higher degree of
confidence and robustness.
We process our All-SAT data from melanoma attractor data of [32] using methods A,
B, and AB. Results are shown in Table II.4 and shows what predictor was selected for each
gene and the accompanying resolution ratio, resolution score, or weighted sum.
PIRIN S100P RET1 MART1 HADHB STC2 WNT 5A
x1 x2 x3 x4 x5 x6 x7
A Predictor set 1357 2137 3146 4357 5124 6124 7124
Resolution ratio 2.57 1.41 1.34 1.30 1.41 1.66 1.31
B Predictor set 1357 2137 3146 4137 5134 6137 7126
Resolution score 1.78 1.77 1.84 1.97 1.99 1.98 2.56
AB Predictor set 1357 2367 3146 4137 5137 6357 7124
Weighted sum 2.06 1.57 1.75 1.61 1.45 1.39 1.88
Table II.4. Melanoma Network Predictor Set Selection
From the results, we can draw several conclusions:
• The iterative steps in regenerating the histogram (or table) retain only cubes (predic-
tor sets) that contain previously selected final predictors. Hence the final predictor
set from each method is a valid satisfying cube of the SAT formula S.
• The final predictor set is present in a select number of attractor cycle orderings. For
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example, the final predictor set selected by methods A, B, and AB are found in re-
spectively 8, 4, and 6 attractor cycle orderings out of the total 5040 possible order-
ings. Hence the algorithm will enable us to generate a few deterministic GRNs.
• Some predictors are common among the predictor sets between the three meth-
ods. For example, all three methods select f1 = {x3,x5,x7} (PIRIN predicted by
RET 1,HADHB,WNT 5A) as well as f3 = {x1,x4,x6}. We can conclude this pre-
dictor is highly likely to be a final predictor in the GRN. Also, a majority of the
predictors selected by the three method share common input genes. For example,
the predictor selected by all methods for gene x2 (S100P) contain 2 common genes
{x3,x7} (RET 1,WNT 5A), indicating these 2 genes are likely to be contained in the
final predictor of f2. Similarly f7 has two common genes x1 and x2 for all methods.
• Using the above results, biologists can target their research on gene regulation and
control, focusing on the gene relationships determined by the predictor set results.
II-F. Chapter Summary
Determining the predictor set for a gene regulatory network is important in many applica-
tions, particularly inference and control of the GRN which we discuss in subsequent chap-
ters. In this research, we formulate gene predictor set inference as an instance of Boolean
satisfiability. In our approach, we determine all possible orderings of attractor state data,
generate the CNF encapsulating predictor and biological constraints, and apply a highly-
efficient and modified SAT solver to find candidate predictor sets. The SAT results are
analyzed using three selection methods to produce the final predictor set. We have tested
our algorithm on attractor state data from a melanoma study, and determined the predictor
sets for this GRN.
The results of this research, however, only reveals the predictor set (topology) of the
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GRN. Our next step is to determine the gene regulating function (logic) of the genes in the
GRN to fully define the BN. In the next chapter, we describe a logic synthesis method for
determine gene functions for a GRN using a SAT-based logic synthesis approach.
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CHAPTER III
DETERMINING GENE FUNCTION IN BOOLEAN NETWORKS USING SAT
There are many instances where the circuit topology of the GRN is known, but the logic
function of each node in this topology is not. In addition, a number N of measurements
on the gene expression of the GRN are given or are known. Using this information, this
chapter will derive SAT based algorithms which yield the logic of every node in the GRN
so that the N gene expression measurements and topology are satisfied. If N is too small,
then a multitude of GRNs may satisfy the observed behavior, yielding a reduced certainty
in the final result due to lack of data. We will also study the behavior of the number of
satisfying GRNs with respect to the number of observations N.
1
III-A. Background
In the cell, genes interact and communicate using a complex interconnected network called
the gene regulatory network (GRN) [33]. The GRN and gene expression defines cell func-
tion and behavior. An accurate model of the GRN is necessary for understanding cell
behavior, for learning how genetic diseases arise and for developing intervention strategies
to treat such diseases.
In many situations, biologists can produce gene predictor sets or connectivity graphs,
denoting which genes act upon or regulate each other. While gene predictor sets or con-
nectivity graphs show how genes are interconnected, they do not provide any information
about the regulating function of the genes. Predictor sets are generally useful, but without
information about the regulating function, they cannot be used to simulate the dynamic in-
1Part of the data reported in this chapter is reprinted with permission from ”Determining
Gene Function in Boolean Networks using Boolean Satisfiability” by Pey-Chang Kent Lin,
Sunil P. Khatri. IEEE International Workshop on Genomic Signal Processing and Statistics
(GENSIPS) 2012, Dec. 2012, pp. 1-4, Copyright 2012 by IEEE
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teraction between genes which is crucial for the intervention and control of the GRN. Thus,
a major goal for the genomics and the medical field is to determine the regulating function
of the genes in the GRN.
At the same time, biologists may have prior knowledge of the GRN, gained through
observations of gene expression or pathway information. These observations provide in-
sight into the GRN state and, in turn, the gene regulation function. Such observations can
be complete or partial, and may curated from different sources or databases.
The problem then is how to determine the gene function and create a complete and
functional GRN model that matches the predictor set and gene expression observations.
Assuming a Boolean network model [12] for the GRN, the gene expression for a single
gene is a binary value (expressed or not expressed) and the gene regulation function is
represented as a Boolean logic function. For each time step, all genes are assumed to
update at the same time, and the value of all genes at a particular time step represents a
state in the GRN at that time step. In this discussion, we present an efficient approach to
assign a logic function to each gene, given a predictor set, such that the gene expression
observation are matched.
In this work [29], we leverage mathematical tools from the field of logic synthesis in
digital circuit design. Logic synthesis techniques have been recently applied to genomics
in [41, 42, 27, 30, 28]. In order to determine gene function, [41] uses Karnaugh maps (K-
maps) to explicitly generate two-level logic functions based on pathway information for a
Boolean network.
In this chapter, we develop a general Boolean satisfiability (SAT) based implicit method
to select logic functions and generate BNs that match a predictor set and gene expression
observations. In our method, all possible logic functions are implicitly explored for each
gene, based on the predictor set, with a multiplexer (MUX) selecting one of these func-
tions for each gene. The resulting logical circuit is duplicated, and each copy is assigned
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one of the observed gene expression observations. All copies (now represented as a SAT
formula) are then solved in parallel by linking the MUX selectors of each copy, and using
a SAT-solver to select a function for each gene, and generate a BN that satisfies all input
observations. Where more than one valid selection exists, our method generates a family
of satisfying Boolean networks.
III-B. Previous Work
One commonly used representation scheme for GRNs is the Boolean network (BN) [12]. In
this model, genes are binary valued (expressed or not expressed), and can act on (regulate)
other genes. Regulation is represented using Boolean functions. In the BN, each gene takes
its inputs (the values of its regulatory genes) and produces a new output value according
to its Boolean function. All genes in the BN update synchronously, and the values of the
genes at a given point of time represent the state of the BN at that time. In reality, gene ex-
pression is continuous; however a discrete model like BN is preferred because many genes
exhibit switch-like behavior [19] and the discrete model simplifies analysis. Furthermore,
the Boolean network is inherently a logic circuit, and a vast number of techniques from the
field of logic synthesis can be applied to BN.
One such logic synthesis technique is the Kaurnaugh Map (K-map) [43] which was
used in [41] to assign logic function to genes and generate Boolean networks from a priori
gene pathway information. The K-map is an explicit method to represent and to simplify
a Boolean function. Pathway information is used to create partially filled K-Maps which
describe the update functions (or the next state functions) for each of the genes in an incom-
pletely specified manner. Minimization of the functions in each K-map yields a family of
Boolean networks. One issue with this approach is that logical conflicts can arise between
different update functions obtained in this manner from the pathway information. The
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paper attempts to resolve these conflicts by perturbing the pathway information, possibly
leading to a vastly different network.
One characteristic of assigning logic to the update function given a predictor set, is that
in a predictor set, the gene connections or ”wiring” is fixed. Hence, the problem is how to
determine the logic function of each gene, to obtain the GRN. Similar situations arise in
digital design (an example is the wire planning problem in which wires or communication
channels are placed before logic synthesis [44]). One method to approach this problem uses
SPFDs (sets of pairs of functions to be distinguished) [45] which expresses the functional
flexibility of nodes in a Boolean network. In [46, 47], SPFDs have been used to optimize
Boolean networks. One drawback is that SPFDs are usually implemented using Boolean
Decision Diagrams (BDDs), which do not scale well due to an exponential memory usage
for some classes of logic functions.
Other logic synthesis techniques [48, 49], which assign logic from state transition di-
agrams, start with state information about the circuit, and assign logic which optimally
minimizes the number of gates needed to implement the logic. As mentioned, the predic-
tor set (and hence the wiring) in our problem is fixed, and as such, these logic synthesis
methods cannot be used, since they may change the wiring to minimize the logic.
This method we present uses a Boolean satisfiability (SAT) based method to assign
logic. Many logic synthesis algorithms are based on SAT, and there are several efficient and
well-developed SAT solvers [23, 25]. In the context of genomics, SAT has been applied
to the analysis of GRNs. In [50], a method is presented for inferring GRN parameters by
expressing GRN constraints in a SAT formula. In [51], a model checking method (based
on SAT) is presented to find all attractors in a Boolean network. Boolean satisfiability
is also used in [28] to infer the predictor set of the GRN from attractors, and determine
optimal drug selection for cancer therapy. Our approach is fundamentally different in that
we generate a family of BNs for a predictor set given binary valued gene expression data.
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III-C. Our Approach
III-C.1. SAT-based Formulation for Gene Function Assignment
In our approach, the problem of gene function assignment is transformed into an instance of
Boolean satisfiability, such that each satisfying solution is an assignment of gene functions
in accordance to the input predictor set and gene expression states. The SAT formulation is
done in two distinct steps – 1) circuit construction from the predictor set and 2) constraining
the solution space using the gene expression states.
III-C.1.a. Circuit Construction from the Predictor Set
The first step is to construct a SAT-based circuit that implicitly represents all possible BNs,
based on prior knowledge of the predictor set. From the predictor set, we can determine the
wiring of the genes. A predictor states which genes regulate the target gene, or in circuit
terms, which genes are wired to the input of a target gene.
To assign the function for a gene xi, our approach implicitly enumerates all possible
functions {gi1,gi2, . . .} and then selects one function as a solution. Thus in our circuit con-
struction, for each gene, all possible functions are enumerated, and a multiplexor (MUX)
is added to select exactly one output from all the functions. The inputs to the MUX are
the outputs of the functions, and a select signal si controls which function to select as the
output for gene i. As such, the MUX selection determines which function is assigned to
the gene.
The circuit is then converted into a CNF formula. Each function (including the MUX)
has a CNF formula associated with it. The formula is true if and only if the variables
representing the gate’s inputs and outputs take on values consistent with its truth table.
One method to write the corresponding CNF of a Boolean formula is using implica-
tions and Boolean transformations. The basic transformation of an implication a → b into
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CNF is the single clause (a+b). The implication states that if a is true (1), then b is also
true (1). We can examine the clause (a+b) and see that if a = 1, then a = 0. As such, for
the clause to be satisfied (evaluate to 1), b must be set to 1.
For example, consider a 2-input OR gate (gi) with x and y as inputs and z as output.
For an OR gate, the output is 1 if and only if one of the inputs are 1. As such, we have the
following two implications:
z → x+ y (3.1)
x+ y → z (3.2)
For the first implication z → x+ y (Equation 3.1), we write the corresponding clause.
(z+ x+ y) (3.3)
This clause is already in CNF format, so no further transformation is needed.
For the second implication x+y→ z (Equation 3.2), we again write the corresponding
clause.
(x+ y+ z) (3.4)
The clause (Equation 3.4) is not in CNF format, so we use transformations such as
DeMorgan’s laws to convert it into CNF.
(xy+ z) (3.5)
(x+ z)(y+ z) (3.6)
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The CNF formula Gi is the conjunction of the above clauses (Equations 3.3, 3.6) and
is written as:
Gi = (z+ x+ y) · (x+ z) · (y+ z) (3.7)
The CNF for the entire circuit S obtained from steps 1) and 2) above is constructed
by forming the conjunction of all CNF formulas for all the gates in the circuit. If there are
n gates in the circuit, then the CNF formula for the entire circuit is written as shown in
Equation 3.8.
S =
n
∏
i=1
Gi (3.8)
In logic synthesis, the inputs to a predictor or a function are alo called the support. In
general, the total number of possible functions is 22N for a gene with N inputs. However,
we consider only those functions that have a true support of N inputs. The true support of a
function are the inputs that a function is actually dependent on. In our method, we require
that a function must depend on all inputs specified by the predictor.
For example, with a gene x with 2 inputs y and z, and we are considering the function
x = yz+ yz. Since this function can be simplified to x = y, it depends on only one input,
and is not a true support of the two inputs and will be disregarded in our method. The
function x = yz does depend on both inputs, and thus would be considered in our method.
The total number of functions FN with true support of N inputs can be calculated as shown
in Equation 3.9.
FN = 22
N
−
(
N
N−1
)
FN−1−
(
N
N−2
)
FN−2− . . .−
(
N
0
)
F0 (3.9)
F0 = 22
0
= 2 (3.10)
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III-C.1.b. Constraining SAT Solution Space Using Gene Expression States
As is, the circuit of the previous step describes all possible BNs. To constrain the solution
space to obtain one or a subset of BNs for our GRN, we constrain the circuit to make it
satisfy gene expression states. A gene expression state is a measurement of the dynamic
behavior of the GRN, containing information of the gene state at a time point t, as well as
at the next time point t+1. In the state transition table (an example is shown in Table III.1),
a gene expression state is a minterm (row) on the truth table of the table, and consists of a
pair of states (S1,S2). This mandates that if the GRN is in state S1 at time t, it will transition
to state S2 at time t+1. Note that table III.1 shows all possible minterms or observations of
the GRN. However in practice, we may only have a limited number of observations. Our
method determines a SAT solution that satisfies the predictor set and limited number of
gene observations.
The overall goal of our approach is, for each gene, to select a function which matches
all gene expression states (minterms of the state transition table). In our approach, if there
are M minterms, we duplicate the circuit M times. Each circuit copy is assigned a minterm,
with the gene values fixed according to the minterm. The select signals for all the MUXes
for any gene xi are connected together in each of the M copies of the circuit, to ensure that
the same function for xi is selected in all the M circuit copies.
The solution is an assignment of the variables in S such that S is satisfied. The assign-
ment of the variables corresponding to the MUX select lines for any gene xi denote which
function was selected for the gene xi and hence specifies a Boolean network. Depending
on the gene expression states used, there may be more than one valid solution, in which
case performing an All-SAT will generate all possible BNs that match the gene expression
observations.
Alternatively, the method can be done on a single copy of the circuit. Each minterm is
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tested in order, and the circuit is solved using All-SAT to find all results that satisfy the ith
minterm. The conjunction of these results and S form a new circuit S before the (i+ 1)th
minterm is processed. This computation was found to require significantly more runtime
than the circuit duplication method.
III-C.1.c. Example
To illustrate the method, we consider a small 3 gene example. Let us label the genes in our
example Boolean network as genes a,b, and c, with the following gene logic functions:
a′ = b+ c
b′ = ac
c′ = a+b
Current state Next state
a b c a′ b′ c′
0 0 0 1 1 0
0 0 1 1 1 0
0 1 0 0 0 1
0 1 1 1 0 1
1 0 0 1 0 1
1 0 1 1 0 1
1 1 0 0 0 1
1 1 1 1 0 1
Table III.1. Example 3-Gene State Transition Table
In the notation, a′,b′,c′ are the next state variables of a,b,c respectively. From these
functions, we can derive a state transition table (Table III.1) which describes the next state
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in the BN given a present state. The predictors for each gene of our example are shown in
Figure III.1a), and listed as follows: pa = {b,c}, pb = {a,c}, and pc = {a,b}
A predictor pi = { j,k, . . .} lists the set of genes { j,k, . . .} which predicts (regulates)
the activity of gene i. Note that in our problem, the logic functions for a′,b′, and c′ are un-
known, and are to be determined from gene expression observations. The gene expression
observations that are provided are any subset of the 8 rows of Table III.1.
Figure III.1 demonstrates the circuit construction. Focusing on gene a, we note it has
2 inputs b and c, meaning there are F2 = 10 possible functions (ga1 ,ga2, . . . ,ga10) with a
true support of 2 inputs. After enumerating the 10 functions, a MUX and select signal
sa is added to select exactly one of the function outputs, as shown in Figure III.1b). A
similar construction is performed for genes b and c, with MUXes and select signals sb and
sc respectively.
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Fig. III.1. Circuit construction example: a) predictor set shown as connectivity graph and b)
function enumeration and MUX for gene a shown in detail
In the example, let us assume that we have the following 3 gene expression states
{a,b,c,a′,b′,c′} ∈ {(001110),(110001),(101101)}. We duplicate the circuit 3 times, as-
signing each copy one of the gene expression states. Accordingly, the MUX select signals
for gene a are connected together across all 3 copies of the circuit, as are the MUXes for
genes b and c.
Generally, we may have a limited number of gene expression states (in the example,
we had 3 out of a possible 8 states). In such situation, there can be several BNs which match
the observations as multiple sets of functions can be valid for the input. Using All-SAT will
implicitly generate all possible satisfying BNs. From the 3-gene example with only 3 gene
expression states, there are 4 possible solutions, of which one solution corresponds to the
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correct BN. To narrow the search, the results can be pruned using curated, partial, or prior
biological information. For example, gene expressions or pathway information for some
genes may be known from other research or databases. Or biologists may want to reason
on the networks assuming the presence of specific gates or transitions on some genes (for
example, gene a represses gene b). This new information restricts the solution space by
providing our method additional logical constraints, and can be added to our algorithm
using the same exact steps as described in our approach.
Additionally, our method can detect logical problems in the input data. If the CNF S is
UNSAT (not satisfiable), there is no possible assignment of logic functions that satisfies the
gene expression observations and the predictor set. This result may occur if there is an error
in either the gene expression observations or predictor set. For example, if the predictor set
was inferred wrongly, the gene expressions were measured incorrectly, or gene expression
data from a different GRN were added, can produce an UNSAT result. In such situation,
our method can be rerun on a modified predictor set, or the gene expression data can be
analyzed to determine which genes is causing the logical error.
Let us examine an example with an UNSAT result. Consider that we have a gene a
which is predicted by b and c. Let us assume that we are given gene expression observa-
tions {a,b,c,a′,b′,c′} ∈ {(000000),(000100)}. We observe that in the first observations
(000000), b = 0 and c = 0, with a′ = 0. However, in the second observation (000100),
b = 0 and c = 0, with a′ = 1. Both b and c have the same values in these two observations,
but a′ has a different value. Logically, this cannot occur since a function cannot have two
different outputs for the same input. The CNF as constructed contains all valid Boolean
functions and since no such Boolean function exists for this logical conflict, the result is
UNSAT.
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III-D. Experimental Results
III-D.1. Model Implementation
We evaluate the SAT-based method for determining the BN on two GRNs, one synthetic
(randomly generated) and one real (p53 network [41, 52]). We first investigate the senstivity
of our method regarding the number of available gene expression observations, and then
we demonstrate our method on attractor data from the p53 network.
The p53 network is well-studied in genomics and medicine, due to the involvement
of p53 gene in many human cancers. p53 is a tumor suppressor gene and is a transcrip-
tion factor for many downstream genes involved in controlling cell cycle, repairing DNA
damage, and inducing apoptosis (cell death) for example. The main pathways for p53 [53]
involve DNA damage in the form of breaks in the DNA strand, as shown in Figure III.2 In
the figure, forward arrows represents activation, while arrows with a line represents repres-
sion. The presence of the external signal dna dsb (DNA strand break damage) activates
AT M, which in turn represses Mdm2, allowing for activation of p53. The expression of
p53 blocks replication of DNA (a necessary response when DNA is damaged). From these
pathways, [41] obtained the corresponding Boolean functions.
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Mdm2
dna_dsb
ATM
p53
Wip1
Fig. III.2. p53 pathways
In our experiments, the function of each gene in these networks is known, but hidden
from our algorithm. We extract both the predictor set and gene expression observations to
test our algorithm with. The regulating logic functions of the synthetic and p53 GRNs are
shown in Tables III.2 and III.3 respectively (these are kept hidden from our algorithm).
Gene Regulating Function
x1 x2 + x4 + x5
x2 x1x3x5
x3 x1x2x4
x4 x1(x3x5 + x3x5)+ x1(x3x5 + x3x5)
x5 (x1 + x2 + x3)
Table III.2. Boolean Regulating Functions for Synthetic 5-Gene Network
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Gene Regulating Function
dna dsb (DNA damage is an external signal)
AT M Wip1(AT M+dna dsb)
p53 Mdm2(AT M+Wip1)
Wip1 p53
Mdm2 AT M(p53+Wip1)
Table III.3. Boolean Regulating Functions for p53 Network
Our method uses an open-source and efficient exact SAT-solver, MiniSAT v1.14 [23].
Shell scripts were created to invoke MiniSAT and to implement the All-SAT functionality.
All tests were implemented and run on a Core 2 Duo Mac OSX machine with 4 GB ram.
Runtimes depend on the input predictor set and number of gene expression observations,
but in our tests, each SAT operation is less than 1s. Accordingly, All-SAT runtime takes
approximately n seconds for n satisfying solutions.
III-D.2. Method Sensitivity to Input
To investigate how the number of solutions (the number of satisfying BNs) depends on the
number of available gene expression observations, we measure the sensitivity of our SAT
algorithm in the following manner. For a GRN with n genes, there are 2n gene expression
states in total, which completely determines the GRN. To test the sensitivity of the number
of solutions to the number of gene expressions observations i, we randomly select i gene
expressions from the 2n total, and run our algorithm to see how many surviving solutions
there are. Because the number of surviving solutions can change depending on the specific
gene expressions selected, we resample x times, and find the mean number of satisfying
solutions among the x samples. We repeat this process for different values of i between 1
and 2n.
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Fig. III.3. Plot of # of mean solutions vs # of gene expressions observations (IO pairs)
In Figure III.3, we show the sensitivity of the algorithm by plotting of the average
number of satisfying solutions against i (the number of gene expression observations). For
each value of i, we re-sampled x = 100 times, and all satisfying solutions were recorded.
The mean number of solutions is plotted.
From the plot, we observe that as additional gene expressions are included in the
algorithm, the solution space reduces exponentially until only a few surviving solutions
remain. At this point, adding more gene expressions do not significantly change the size
of the solution space. In both examples, the inflection point appears to be i = 16 (roughly
half the total number of gene expression observations). These plots show the importance
of including additional gene expressions in reducing the size of the solution space.
These results show that our method works well for GRNs with fewer genes. For
a network with large number of genes, a corresponding large number of gene expression
observations is needed to reduce the solution space and keep the computation under control.
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An advantage is that our method is inherently parallelizable. By cofactoring2 on x and x,
where x is a variable of S, we can partition S into 2 problems, Sx and Sx. Each of these can
run in parallel on separate machines. In general, we may partition S into 2k partitions (by
using k variables) and run each partition in parallel.
III-D.3. Function and BN Results for p53
We validate our SAT algorithm using the p53 network. Let us assume that we have the
attractor states as input to our algorithm. Using attractor states is a reasonable assumption
since in the long run, a BN would transition to these attractor states, thus these states are
most likely to be measured in practice. From the logic function of the p53 network, we
observe 2 attractor cycles containing 8 attractor states in total. We define the state space as
[AT M, p53,Wip1,Mdm2] and the attractor cycles are a singleton cycle if dna dsb = 0 and
a 7 state cycle if dna dsb = 1 as shown Table III.4.
dna dsb Attractor Cycle
0 (0000)
1 (1000)→ (1100)→ (1110)→ (0110)→ (0111)→ (0011)→ (0001)
Table III.4. Attractor Cycles and States for p53 Network [AT M, p53,Wip1,Mdm2]
These attractors become the 8 gene expressions used as input to our method and All-
SAT on the CNF results in 72 possible satisfying BNs out. Furthermore, we observe that
one of the 72 BNs has the correct logic function for the p53 network. If we count the num-
ber of selected functions per gene, we find that for AT M, p53,Wip, and Mdm2, there are 6,
4, 1, and 3 functions respectively. These results can help biologists tune their experiments
to understand gene regulatory function.
2The cofactor of S(x1, . . .xi . . .xn) wrt xi is Sxi(x1, . . .xi . . .xn) = S(x1, . . .xi = 1 . . .xn)
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III-E. Chapter Summary
In this chapter, we have presented an efficient and general SAT-based method for deter-
mining logic functions from gene expression data. Our approach implicitly explores all
possible logic functions for each gene based on the predictor set, and selects functions that
match the gene expression observations using a SAT formulation. Each SAT solution is a
Boolean network, and the results of our method generate a family of BNs that match the
predictor set and gene expressions. Our SAT-based method is validated on two GRNs and
demonstrates the importance of gene expression data with regards to constraining the space
of satisfying BNs. We also test the method on the p53 network and show how our results
can be used to select the gene functions. Due to its generality and efficiency, this algorithm
can easily be extended to large networks, and can be augmented to utilize gene expression
data from multiple sources.
Thus far, our inference of the GRN predictor set and regulating function has been done
using binary valued gene expression data. In practice, gene expressions are initially mea-
sured as continuous values, from which the values are converted to binary values. While
binary gene expressions simplify our analysis, continuos gene expression may provide a
richer and more detailed observation of the gene state and GRN. The next chapter explores
methods to infer the GRN from continuous gene expression data.
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CHAPTER IV
PREDICTOR RANKING USING MODIFIED ZHEGALKIN FUNCTIONS
Inference of the underlying gene regulatory network structure (i.e. predictors and func-
tions) from gene expression is an important challenge in genomics. With continuing im-
provements in microarray technology, the ability to measure expression levels of many
genes has improved significantly, making available large amount of gene expression data
for analysis. In previous chapters, all gene expressions have been assumed to be digital in
nature. However, actual gene expressions (from microarrays for example) are continuous.
On the other hand, many genes have been observed to exhibit switch-like or Boolean be-
havior. In this chapter, we utilize Zhegalkin polynomials to express the Boolean behavior
of gene expression in an analog or continuous manner. Given gene expression data in the
form of microarray measurements normalized to the unit interval, we present a method
for ranking and selecting predictors which fits the data with the least mean square error
according to the Zhegalkin function. Our methods are validated on synthetic gene expres-
sions from a mutated mammalian cell-cycle network and then demonstrated on measured
gene expressions from a melanoma network study. The results of our approach can be used
to identify potential genes in future expression experiments or for possible targeted drug
development experiments.
IV-A. Background and Previous Work
Advances in microarray technology have allowed biologists the opportunity to measure the
expression of thousands, or even tens of thousands of genes simultaneously. This large
amount of gene expression data can be used for analysis for modeling and inferring the
gene regulatory network. Several methods have been proposed to model the expression
data, particularly Boolean networks which use binary (Boolean) representation for gene
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expression. Boolean networks (BNs) [12] is commonly used for GRN inference [38, 41, 27]
and intervention [42, 30]. In the Boolean network, gene expression are binary valued, either
1 (ON) or 0 (OFF). Binary value representation is used as many genes have been observed
to exhibit switch-like behavior. In the Boolean network, gene expressions are updated at
the following time point according to Boolean functions at the current time point. The
deterministic nature of Boolean network allows for fast analysis and application of logic
synthesis tools. While Boolean networks exhibit many observed characteristics of gene
regulatory networks, Boolean networks cannot model continuous levels of gene expression
values.
In context of RNA and protein production, actual gene expression is more complex
and is measured as a continuous value from measurement techniques such as microarrays.
Other models have been proposed to model the GRN with continuous value gene expression
such as Differential Equations [10], Linear Equations [11], Continuous Networks [14], and
Stochastic Gene Networks [15]. While such models can determine continuous functions to
model the gene expresion data, continuous functions in general cannot capture the Boolean-
like behavior of genes.
In [54], a model was proposed to combine continuous gene expression and discrete
Boolean-like behavior. This combined model is based on Zhegalkin polynomial func-
tions [55]. Zhegalkin functions is an alternative representation of Boolean functions using
continuous values. These Zhegalkin functions can represent any Boolean function hav-
ing an output value within the unit interval [0,1] if input variables are also within the unit
interval. In [54], it was demonstrated how Zhegalkin function can be used to model the
next state equation for a given a predictor (target gene and input genes), and time-series
expression data for yeast model dataset.
Our approach uses Zhegalkin functions to infer gene predictors and functions from
normalized continuous gene expression data. As opposed to [54] which uses a linear ex-
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pression function, our method uses a sigmoid expression function to more accurately rep-
resent the gene expression. Another key difference, [54] only finds a single regulating
function for a given predictor and gene expression data, while our methods finds the best
predictor and function for a target gene given just the gene expression data, by searching
across all possible predictors and functions in the GRN through a ranking of best fitting
predictors by mean-squared error.
IV-B. Approach
IV-B.1. Network Model
As described earlier, the Boolean network model can not be used with continuous gene ex-
pression values. Instead we use a modified model similar to BN but which uses continuous
expression values and Zhegalkin functions (subsection IV-B.2) in place of Boolean values
and Boolean functions. In the modified model, we define a set of nodes {x1,x2, . . . ,xn} and
Zhegalkin functions {z1,z2, . . . ,zn}. Each node xi is a gene, and each gene is associated
with a Zhegalkin function zi. The value of a gene is a continuous variable, xi ∈ [0,1] where
the value can be within the unit interval, and is updated according to the associated Zhe-
galkin function zi. Thus, the gene state xi can represent varying levels of expressions from
fully expressed (xi = 1), not expressed (xi = 0), and any expression level in between.
IV-B.2. Zhegalkin Polynomial Function
To model the dynamics of continuous gene expression values and provide a continuous
representation of Boolean function, our algorithm utilizes Zhegalkin polynomial func-
tions [56]. Following is a description of a Zhegalkin polynomial function.
Definition IV.1: A Zhegalkin polynomial function with n variables is given by Equa-
tion 4.1.
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f (x1, . . . ,xn) = a0 +
n
∑
j=1
a jx j +
n
∑
k=2
k−1
∑
j=1
a jkx jxk +
n
∑
l=3
l−1
∑
k=2
k−1
∑
j=1
a jklx jxkxl + . . .+a1...nx1 . . .xn
(4.1)
The Zhegalkin function is a linear function consisting of coefficients and products of
the input variables. The first term, a0 is a constant. The second term ∑nj=1 a jx j is weighted
sum of all possible single inputs. The third term ∑nk=2 ∑k−1j=1 a jkx jxk is weighted sum of all
possible combinations of two inputs, and so on. The last term is a weighted product of all
inputs.
The coefficients or weights a0,a1, . . . ,a1...n of a Zhegalkin function are called Zhe-
galkin coefficients. In general, any Boolean function can be converted to a Zhegalkin func-
tion by selecting the appropriate Zhegalkin coefficients. In [56], it was determined that the
possible range of values for the Zhegalkin coefficients to define any Boolean function of
input size n are listed in Table IV.1.
Coefficient Set of Possible Values Notation
a0 0,1 A0
a j -1,0,1 A1
a jk -2,-1,0,1,2 A2
a jkl -4,-3,-2,0,1,2,3,4 A3
.
.
.
.
.
.
.
.
.
a123...n −2(n−1), . . . ,−1,0,1, . . . ,2(n−1) An
Table IV.1. Possible Values for Coefficients of Zhegalkin Function
To demonstrate how Zhegalkin function can represent a Boolean function, we show
two simple examples. Consider two Boolean functions:
f B = x1x2
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gB = x1 x2 + x1x2
The truth tables for f B and gB are shown in Tables IV.2 and IV.3. We select the
appropriate coefficients to find the corresponding Zhegalkin functions are:
f Z = x2− x1x2
gZ = 1− x1− x2 +2x1x2
Plotting the Zhegalkin functions as a surface plot, we observe in Figures IV.1 and IV.2
that the corner points (where the inputs are 0 or 1) match the Boolean function output and
the surface confirms to expected values for continuous Boolean function in the unit interval.
x1 x2 f B
0 0 0
0 1 1
1 0 0
1 1 0
Table IV.2. Truth Table for f B = x1x2
x1 x2 gB
0 0 1
0 1 0
1 0 0
1 1 1
Table IV.3. Truth Table for gB = x1 x2 + x1x2
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Fig. IV.1. Zhegalkin function f Z = x2− x1x2 for Boolean function f B = x1x2
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Fig. IV.2. Zhegalkin function gZ = 1 − x1 − x2 + 2x1x2 for Boolean function
gB = x1 x2 + x1x2
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IV-B.3. Sigmoid Function
The inputs of the Zhegalkin function as used by [54] are continuous gene expression values
represented in a linear function. However, actual gene expression is more complex and
depends on several simultaneous and competing factors such as RNA/protein formation
or degradation, chemical reaction rates, and molecular transport. It has been observed
that the expression values tends to saturate at low and high gene activity and has been
suggested that a more accurate representation of continuous gene expression is a sigmoid
function [57, 58].
Definition IV.2: A sigmoid function has a ”S” shape curve defined by Equation 4.2.
s(t) = 1/(1+ e−t) (4.2)
Figure IV.3 plots the linear and sigmoid function to compare the two functions. Note,
the sigmoid function s(x) is shifted and scaled to the unit interval.
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Fig. IV.3. Linear function x compared with sigmoid function s(x) = 1/1+e−12∗x+6 over the
unit interval
In our approach, the Zhegalkin function can accept either the linear x or sigmoid s(x)
representation of gene expression. In section IV-C, we will compare the accuracy between
the two representations.
IV-B.4. Predictor Ranking Algorithm
Algorithm 1 describes the general procedure for our predictor ranking. The inputs to our
algorithm are gene expression observations X and Y with m observations or samples of
each. In detail, Xi is the observed current state of the network, and Yi is the resulting
next state of the network. X can be the linear representation or sigmoid representation as
specified at runtime. Given a target gene xi, our algorithm determines a ranking of the best
predictors for xi with minimal error in the expected output (best fitting Zhegalkin function
upon X ) and the actual output Y .
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In line 2 of the algorithm, the method iterates through all possible predictor combina-
tions p j ∈ p for the target gene xi. For each p j, the method considers all valid Zhegalkin
functions zk ∈ z (line 3) by iterating over all possible coefficient combinations correspond-
ing to Boolean functions. In line 4, the algorithm determines the mean squared error (MSE)
of the expected output and actual output for each Zhegalkin function zk. The MSE is used
to measure how well the Zhegalkin function fits or matches the actual output expression
values. In line 6, the minimum MSE of all Zhegalkin functions for predictor p j is chosen
as representative MSE for p j. After the MSEs for all predictors have been determined,
the predictors are sorted by their MSE (line 8), and the ranked predictors (as well as its
Zhegalkin function) and corresponding MSE are returned.
Algorithm 1 Pseudocode of Predictor Ranking
1: PRED RANK(X ,Y,xi)
2: for all predictor combinations p j ∈ p for xi do
3: for all valid Zhegalkin functions zk ∈ z for p j do
4: MSEzk = 1/m∑ml=1 (zk(Xl)−Yl)2
5: end for
6: MSEp j = min(MSEz)
7: end for
8: sort p by MSEp
9: return ranked (p,MSEp)
The algorithm returns a ranked list of predictors rather than a single predictor with
the lowest MSE for a several reasons. The main reason is the actual or correct predictor is
expected to be one the top ranked predictors as the actual predictor should best match the
input data resulting in low MSE. However, the ”correct” predictor may not have the lowest
MSE if the expression samples are not adequately distributed. Ideally, the samples should
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be uniformly distributed throughout the state space. However, limited number of samples
may result in some areas in the state space not adequately represented. For example, if
none of the samples were represented in a particular region, several Zhegalkin functions
or predictors may match equally well. Second, the expression data may be noisy or may
contain errors, resulting in a higher MSE for the ”correct” predictor, and in turn potentially
decreasing its rank. The ranked list ensures that the ”correct” predictor is not prematurely
disqualified from the results.
In general, given adequately distributed expression samples, the top ranking predictor
can be selected as the inferred predictor, if the top ranked predictor has significantly lower
MSE than the second ranked predictor. In the next section, we describe one method for
selecting a predictor from the ranked list. Otherwise, if several predictors have similarly
low MSE (due to sample distribution or noisy data), the ranked list can be used to help
guide follow-up lab experiments to test and verify those particular predictors.
IV-C. Results
We demonstrate our predictor ranking method on two GRNs. To validate our method,
we use the mutated 9-gene mammalian cell-cycle network using synthetic gene expression
data. We use both linear and sigmoid representation for gene expression values. From these
results, we determine a predictor selection method and find the sigmoid representation is
more accurate. Lastly, we apply both ranking and selection method on melanoma study
data assuming a sigmoid representation.
IV-C.1. Mutated Mammalian Cell-Cycle Network
In this experiment, we use a mutated mammalian cell-cycle network to illustrate and val-
idae our approach. For a normal mammal, the cell cycle is tightly controlled through ex-
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tracellular signals that indicate whether a cell should divide/grow or not. These signals
activate the gene CyclinD (CycD) which is a key gene in mammalian cell-cycle. Another
important gene is retinoblastoma (Rb) which is a tumor-suppressor when the other cyclin
genes are not expressed. Another key gene is p27, which when active, represses the cyclin
genes, stopping the cell cycle. In the mutated mammalian cell-cycle, p27 is mutated and
is always off, leading to possible cell cycle in the absence of extracelluar signals. For the
mutated 9-gene mammalian cell-cycle network, [59] determined the regulating functions
for genes to be those shown in Table IV.4. To validate our method, we will use the regu-
lating functions to create synthetic continuous gene expression values, on which we apply
our algorithm (linear and sigmoid) to determine predictor rankings for target genes in the
mutated network. In this setup, the actual functions and predictors are hidden from our
algorithm.
Gene Regulating Function
x1 CycD extracellular signal
x2 Rb CycD ·CycE ·CycA ·CycB
x3 E2F Rb ·CycA ·CycB
x4 CycE E2F ·Rb
x5 CycA (E2F ·Rb ·Cdc20 · (Cdh1 ·UbcH10))+ (CycA ·Rb ·Cdc20 · (Cdh1 ·UbcH10))
x6 Cdc20 CycB
x7 Cdh1 (CycA ·CycB)+Cdc20
x8 UbcH10 Cdh1+(Cdh1 ·UbcH10 · (Cdc20+CycA+CycB))
x9 CycB Cdc20 ·Cdh1
Table IV.4. Boolean Regulating Functions for Mutated 9-Gene Mammalian Cell-Cycle Net-
work
To synthesize normalized and continuous gene expression data similar to those mea-
sured in practice, we perform the following procedure. From the Boolean functions in
Table IV.4, we create a state transition (truth) table listing all current states and next states.
Each pair of current and next state forms a minterm (row) in the table. Since there are n = 9
genes in the mutated network, the state transition table contains 29 = 512 minterms. We
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randomly sample m minterms and convert the binary values of each gene to a continuous
value. The conversion process takes a binary value (0,1) and uniformly and randomly per-
turbs the value up to p, resulting in a continuous value ([0, p], [1− p,1]). The value of p
can be from 0 to 0.5 and is proportional to the number of occurrences of a binary value for
a gene in the set of minterms. For example, if a gene xi has the value 1 occuring 75% in
the set of minterms, p = (0.75) ∗ (0.5) = 0.375, and as such the 1 value is perturbed from
[0.625,1] for gene xi. Each gene will have a different perturbation that is dependent on the
occurances of the binary values 1 and 0 in the the input set.
As an additional constraint to improve runtime, we limit our algorithm to search on
predictors with 4 or less inputs. In general, this is a reasonable assumption as most genes
have been observed to have relatively few inputs. We individually select genes x2 to x9 as
the target gene and then apply our method on the mutated network to determine predictor
rankings for each of these 8 genes. We exclude gene CycD(x1) as it is an extracellular
signal, and thus not predicted by any genes in the mutated cell-cycle network.
Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x1 0.1626 x1,x4 0.0676 x1,x4,x9 0.0501 x1,x4,x8,x9 0.0365
2 x8 0.2268 x1,x3 0.0952 x1,x3,x4 0.0512 x1,x4,x6,x9 0.0377
3 x7 0.2323 x1,x6 0.1030 x1,x4,x5 0.0561 x1,x3,x4,x8 0.0385
4 x3 0.2398 x1,x9 0.1037 x3,x4,x7 0.0592 x1,x3,x4,x9 0.0397
5 x6 0.2425 x3,x4 0.1058 x1,x4,x6 0.0623 x1,x4,x5,x6 0.0405
6 x4 0.2482 x5,x6 0.1062 x3,x4,x5 0.0626 x1,x4,x5,x9 0.0415
7 x5 0.2517 x1,x8 0.1083 x1,x4,x7 0.0660 x1,x4,x5,x8 0.0445
8 x9 0.2572 x1,x7 0.1086 x3,x4,x9 0.0698 x1,x3,x4,x5 0.0446
9 x1,x5 0.1111 x1,x3,x5 0.0705 x1,x4,x7,x9 0.0450
10 x4,x7 0.1251 x3,x4,x8 0.0710 x1,x3,x4,x6 0.0454
Table IV.5. Linear Predictor Ranking by MSE for Gene Rb(x2) in Mutated Network (Top
10 Predictors Shown), Correct Predictor is x1,x4,x5,x9
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Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x7 0.1916 x2,x9 0.0770 x2,x5,x9 0.0532 x2,x5,x8,x9 0.0354
2 x2 0.2007 x2,x5 0.0778 x2,x5,x6 0.0672 x2,x5,x6,x7 0.0409
3 x5 0.2015 x5,x9 0.1127 x2,x4,x9 0.0677 x2,x5,x6,x9 0.0412
4 x1 0.2033 x5,x7 0.1158 x2,x4,x5 0.0699 x2,x5,x7,x9 0.0424
5 x9 0.2051 x2,x7 0.1184 x2,x5,x8 0.0717 x2,x4,x5,x9 0.0438
6 x4 0.2097 x7,x9 0.1210 x1,x2,x9 0.0731 x1,x2,x5,x9 0.0446
7 x8 0.2474 x5,x6 0.1217 x2,x5,x7 0.0755 x1,x2,x5,x7 0.0473
8 x6 0.2585 x5,x8 0.1263 x1,x2,x5 0.0770 x2,x4,x5,x7 0.0478
9 x1,x2 0.1291 x1,x2,x7 0.0788 x2,x5,x6,x8 0.0513
10 x1,x7 0.1308 x1,x4,x7 0.0792 x1,x2,x7,x9 0.0525
Table IV.6. Linear Predictor Ranking by MSE for Gene E2F(x3) in Mutated Network (Top
10 Predictors Shown), Correct Predictor is x2,x5,x9
Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x3 0.0852 x2,x3 0.0222 x2,x3,x5 0.0258 x1,x2,x3,x7 0.0110
2 x2 0.1510 x3,x8 0.0851 x2,x3,x6 0.0316 x2,x3,x6,x9 0.0135
3 x6 0.1816 x2,x6 0.0863 x2,x3,x9 0.0322 x2,x3,x5,x6 0.0143
4 x5 0.2048 x3,x6 0.1000 x2,x3,x7 0.0342 x1,x2,x3,x5 0.0179
5 x7 0.2171 x1,x3 0.1002 x2,x3,x8 0.0387 x1,x2,x3,x9 0.0181
6 x1 0.2418 x3,x9 0.1028 x1,x2,x3 0.0416 x2,x3,x7,x8 0.0184
7 x9 0.2436 x3,x7 0.1188 x3,x7,x9 0.0614 x2,x3,x7,x9 0.0187
8 x8 0.2508 x3,x5 0.1197 x3,x7,x8 0.0628 x2,x3,x5,x8 0.0190
9 x1,x2 0.1220 x3,x5,x8 0.0657 x1,x2,x3,x6 0.0198
10 x7,x9 0.1224 x3,x6,x8 0.0657 x2,x3,x8,x9 0.0198
Table IV.7. Linear Predictor Ranking by MSE for Gene CycE(x4) in Mutated Network (Top
10 Predictors Shown), Correct Predictor is x2,x3
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Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x6 0.1425 x2,x6 0.0581 x2,x6,x7 0.0523 x2,x6,x8,x9 0.0336
2 x3 0.1434 x3,x6 0.0713 x2,x6,x9 0.0528 x2,x4,x6,x9 0.0343
3 x7 0.1651 x2,x3 0.0822 x3,x6,x8 0.0588 x2,x6,x7,x8 0.0360
4 x9 0.1943 x6,x8 0.0839 x2,x6,x8 0.0609 x2,x4,x6,x7 0.0369
5 x2 0.2072 x6,x7 0.0877 x2,x3,x6 0.0612 x2,x3,x6,x9 0.0370
6 x8 0.2281 x3,x7 0.0880 x6,x7,x9 0.0624 x1,x3,x6,x7 0.0376
7 x4 0.2368 x2,x7 0.0976 x3,x7,x8 0.0644 x1,x3,x6,x9 0.0381
8 x1 0.2439 x3,x8 0.0995 x3,x6,x9 0.0656 x3,x4,x6,x8 0.0410
9 x3,x9 0.1038 x2,x4,x6 0.0670 x3,x6,x8,x9 0.0424
10 x4,x7 0.1105 x6,x7,x8 0.0672 x1,x3,x4,x6 0.0425
Table IV.8. Linear Predictor Ranking by MSE for Gene CycA(x5) in Mutated Network (Top
10 Predictors Shown), Correct Predictor is x2,x3,x6,x7,x8
Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x9 0.0126 x1,x9 0.0784 x1,x4,x9 0.0171 x3,x4,x7,x9 0.0106
2 x1 0.2219 x4,x9 0.0985 x7,x8,x9 0.0176 x3,x4,x8,x9 0.0109
3 x5 0.2279 x2,x9 0.1062 x2,x4,x9 0.0186 x4,x7,x8,x9 0.0112
4 x8 0.2416 x7,x9 0.1109 x4,x7,x9 0.0208 x1,x3,x7,x9 0.0127
5 x3 0.2434 x8,x9 0.1156 x3,x8,x9 0.0277 x2,x4,x8,x9 0.0128
6 x4 0.2608 x5,x9 0.1230 x2,x5,x9 0.0305 x4,x5,x8,x9 0.0129
7 x2 0.2653 x3,x7 0.1302 x1,x7,x9 0.0315 x3,x7,x8,x9 0.0131
8 x7 0.2689 x3,x9 0.1345 x1,x3,x9 0.0319 x1,x5,x8,x9 0.0131
9 x7,x8 0.1439 x1,x8,x9 0.0320 x1,x4,x5,x9 0.0133
10 x2,x7 0.1550 x1,x2,x9 0.0322 x1,x3,x5,x9 0.0133
Table IV.9. Linear Predictor Ranking by MSE for Gene Cdc20(x6) in Mutated Network
(Top 10 Predictors Shown), Correct Predictor is x9
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Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x6 0.1231 x6,x9 0.0565 x5,x6,x9 0.0215 x5,x6,x8,x9 0.0173
2 x9 0.1310 x6,x8 0.0965 x1,x6,x9 0.0297 x1,x4,x6,x9 0.0244
3 x8 0.1821 x5,x9 0.1017 x4,x6,x9 0.0493 x1,x5,x6,x9 0.0245
4 x3 0.2088 x1,x6 0.1023 x5,x6,x8 0.0562 x4,x5,x6,x9 0.0252
5 x1 0.2390 x5,x6 0.1048 x6,x8,x9 0.0573 x1,x3,x6,x9 0.0257
6 x4 0.2486 x8,x9 0.1093 x1,x3,x6 0.0578 x3,x5,x6,x9 0.0272
7 x5 0.2520 x3,x8 0.1166 x4,x6,x8 0.0586 x2,x5,x6,x9 0.0286
8 x2 0.2797 x2,x6 0.1168 x2,x6,x9 0.0596 x1,x6,x8,x9 0.0309
9 x3,x6 0.1173 x1,x5,x6 0.0656 x4,x6,x8,x9 0.0358
10 x1,x3 0.1214 x3,x6,x9 0.0659 x2,x4,x6,x9 0.0362
Table IV.10. Linear Predictor Ranking by MSE for Gene Cdh1(x7) in Mutated Network
(Top 10 Predictors Shown), Correct Predictor is x5,x6,x9
Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x7 0.0981 x1,x7 0.1093 x1,x4,x7 0.0681 x1,x3,x6,x7 0.0597
2 x1 0.1924 x3,x4 0.1134 x1,x2,x7 0.0694 x3,x5,x6,x7 0.0619
3 x4 0.2168 x3,x5 0.1356 x1,x6,x7 0.0744 x4,x6,x7,x9 0.0620
4 x3 0.2476 x3,x6 0.1390 x1,x3,x7 0.0749 x1,x4,x6,x7 0.0622
5 x9 0.2487 x6,x7 0.1479 x1,x5,x7 0.0751 x1,x3,x4,x7 0.0623
6 x6 0.2546 x7,x9 0.1482 x3,x5,x7 0.0768 x1,x3,x5,x7 0.0625
7 x5 0.2559 x4,x5 0.1500 x1,x7,x9 0.0781 x1,x2,x5,x7 0.0626
8 x2 0.2565 x4,x7 0.1512 x2,x5,x7 0.0822 x2,x3,x4,x7 0.0647
9 x3,x9 0.1531 x3,x4,x7 0.0829 x2,x3,x6,x7 0.0650
10 x3,x7 0.1587 x5,x6,x7 0.0831 x3,x5,x7,x9 0.0653
Table IV.11. Linear Predictor Ranking by MSE for Gene UbcH10(x8) in Mutated Network
(Top 10 Predictors Shown), Correct Predictor is x5,x6,x7,x9
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Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x7 0.1238 x6,x7 0.0241 x6,x7,x8 0.0202 x3,x6,x7,x8 0.0176
2 x6 0.1502 x5,x7 0.0813 x5,x6,x7 0.0401 x4,x6,x7,x8 0.0182
3 x3 0.2220 x1,x7 0.0957 x1,x6,x7 0.0429 x1,x6,x7,x8 0.0189
4 x8 0.2506 x7,x8 0.0995 x4,x6,x7 0.0494 x5,x6,x7,x8 0.0204
5 x4 0.2652 x3,x7 0.1002 x3,x6,x7 0.0520 x4,x5,x6,x7 0.0206
6 x5 0.2716 x4,x7 0.1064 x2,x6,x7 0.0531 x3,x5,x6,x7 0.0207
7 x2 0.2792 x3,x6 0.1096 x2,x3,x7 0.0605 x2,x6,x7,x8 0.0207
8 x1 0.2884 x6,x8 0.1165 x3,x4,x6 0.0634 x3,x4,x6,x7 0.0208
9 x4,x6 0.1211 x1,x7,x8 0.0657 x1,x5,x6,x7 0.0208
10 x2,x7 0.1264 x5,x7,x8 0.0660 x1,x3,x6,x7 0.0216
Table IV.12. Linear Predictor Ranking by MSE for Gene CycB(x9) in Mutated Network
(Top 10 Predictors Shown), Correct Predictor is x6,x7
Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x1 0.2722 x1,x4 0.1244 x1,x4,x9 0.0404 x1,x4,x7,x9 0.04035
2 x8 0.2815 x5,x8 0.1475 x1,x3,x4 0.0646 x1,x4,x8,x9 0.04050
3 x7 0.3732 x1,x3 0.1503 x1,x4,x5 0.0673 x1,x4,x5,x9 0.04076
4 x6 0.3899 x1,x5 0.1534 x1,x3,x6 0.0745 x1,x4,x6,x9 0.04073
5 x3 0.3901 x5,x6 0.1571 x1,x3,x5 0.0922 x1,x3,x4,x5 0.05836
6 x5 0.3923 x1,x6 0.1583 x1,x5,x9 0.0926 x1,x3,x4,x8 0.06408
7 x9 0.4013 x8,x9 0.1623 x1,x6,x9 0.0951 x1,x3,x4,x9 0.06436
8 x4 0.4068 x7,x8 0.1656 x1,x4,x8 0.0951 x1,x3,x4,x7 0.06441
9 x1,x8 0.1689 x3,x4,x9 0.0954 x1,x3,x4,x6 0.06525
10 x3,x6 0.1774 x1,x4,x6 0.0982 x1,x4,x5,x7 0.06658
Table IV.13. Sigmoid Predictor Ranking by MSE for Gene Rb(x2) in Mutated Network (Top
10 Predictors Shown), Correct Predictor is x1,x4,x5,x9
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Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x2 0.2993 x2,x5 0.0591 x2,x5,x9 0.0064 x2,x5,x7,x9 0.0058
2 x7 0.3034 x2,x9 0.1210 x2,x5,x6 0.0592 x2,x5,x8,x9 0.0060
3 x1 0.3600 x2,x7 0.1552 x2,x5,x8 0.0694 x2,x5,x6,x9 0.0060
4 x5 0.3627 x1,x2 0.1784 x2,x5,x7 0.0698 x1,x2,x5,x9 0.0061
5 x4 0.3699 x5,x7 0.1797 x1,x2,x5 0.0851 x2,x4,x5,x9 0.0261
6 x9 0.4052 x7,x9 0.1840 x2,x4,x5 0.0857 x1,x2,x5,x7 0.0291
7 x8 0.4236 x5,x6 0.1938 x1,x2,x7 0.0871 x2,x4,x5,x7 0.0555
8 x6 0.4286 x4,x7 0.1938 x5,x7,x9 0.0983 x2,x4,x5,x8 0.0572
9 x5,x8 0.1985 x1,x2,x6 0.1138 x2,x4,x5,x6 0.0580
10 x4,x5 0.2099 x2,x4,x9 0.1211 x1,x2,x5,x8 0.0588
Table IV.14. Sigmoid Predictor Ranking by MSE for Gene E2F(x3) in Mutated Network
(Top 10 Predictors Shown), Correct Predictor is x2,x5,x9
Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x3 0.1540 x2,x3 0.0014 x2,x3,x6 0.0252 x1,x2,x3,x7 0.0013
2 x2 0.2384 x2,x6 0.1191 x2,x3,x5 0.0329 x2,x3,x5,x8 0.0014
3 x6 0.3028 x3,x8 0.1287 x2,x3,x8 0.0350 x2,x3,x5,x6 0.0014
4 x5 0.3538 x1,x3 0.1542 x2,x3,x9 0.0597 x1,x2,x3,x5 0.0015
5 x9 0.3688 x3,x6 0.1549 x2,x3,x7 0.0606 x1,x2,x3,x9 0.0015
6 x7 0.3712 x3,x7 0.1852 x1,x2,x3 0.0615 x1,x2,x3,x6 0.0017
7 x8 0.4165 x3,x9 0.1872 x3,x7,x9 0.0915 x2,x3,x6,x8 0.0017
8 x1 0.4243 x1,x2 0.1873 x3,x5,x7 0.1111 x2,x3,x7,x9 0.0022
9 x5,x6 0.1913 x1,x3,x8 0.1131 x2,x3,x8,x9 0.0023
10 x3,x5 0.1915 x1,x3,x6 0.1176 x2,x3,x7,x8 0.0023
Table IV.15. Sigmoid Predictor Ranking by MSE for Gene CycE(x4) in Mutated Network
(Top 10 Predictors Shown), Correct Predictor is x2,x3
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Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x3 0.2598 x2,x6 0.0683 x2,x6,x8 0.0376 x2,x3,x6,x8 0.0098
2 x6 0.2626 x6,x8 0.0948 x3,x6,x8 0.0388 x2,x6,x7,x8 0.0358
3 x7 0.3031 x3,x6 0.1008 x2,x3,x6 0.0397 x2,x6,x8,x9 0.0368
4 x2 0.3443 x3,x7 0.1256 x2,x6,x7 0.0408 x3,x6,x7,x8 0.0370
5 x9 0.3452 x4,x7 0.1287 x2,x6,x9 0.0417 x1,x2,x6,x8 0.0373
6 x4 0.3531 x2,x3 0.1300 x6,x7,x8 0.0657 x3,x6,x8,x9 0.0380
7 x8 0.4170 x4,x6 0.1319 x1,x2,x6 0.0693 x2,x4,x6,x9 0.0380
8 x1 0.4258 x6,x7 0.1348 x2,x3,x7 0.0694 x2,x4,x6,x7 0.0384
9 x2,x7 0.1439 x3,x6,x7 0.0703 x1,x3,x4,x6 0.0385
10 x3,x4 0.1591 x1,x3,x6 0.0714 x1,x3,x6,x8 0.0386
Table IV.16. Sigmoid Predictor Ranking by MSE for Gene CycA(x5) in Mutated Network
(Top 10 Predictors Shown), Correct Predictor is x2,x3,x6,x7,x8
Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x9 0.0011 x1,x9 0.0983 x2,x4,x9 0.0013 x1,x3,x5,x9 0.0008
2 x5 0.3335 x4,x9 0.0988 x1,x4,x9 0.0015 x2,x7,x8,x9 0.0009
3 x8 0.3757 x7,x9 0.1288 x4,x7,x9 0.0015 x2,x4,x8,x9 0.0009
4 x3 0.4063 x2,x9 0.1291 x7,x8,x9 0.0019 x3,x4,x5,x9 0.0009
5 x7 0.4199 x8,x9 0.1308 x1,x7,x9 0.0286 x2,x4,x7,x9 0.0010
6 x2 0.4220 x5,x9 0.1574 x1,x8,x9 0.0288 x1,x3,x7,x9 0.0010
7 x4 0.4262 x3,x9 0.1598 x2,x7,x9 0.0288 x1,x3,x4,x9 0.0010
8 x1 0.4345 x2,x7 0.2270 x3,x7,x9 0.0313 x1,x3,x8,x9 0.0011
9 x7,x8 0.2467 x2,x8,x9 0.0319 x3,x4,x7,x9 0.0011
10 x3,x7 0.2692 x5,x8,x9 0.0321 x2,x5,x8,x9 0.0011
Table IV.17. Sigmoid Predictor Ranking by MSE for Gene Cdc20(x6) in Mutated Network
(Top 10 Predictors Shown), Correct Predictor is x9
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Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x6 0.1722 x6,x9 0.0370 x5,x6,x9 0.0069 x1,x3,x6,x9 0.0062
2 x9 0.1823 x5,x9 0.1009 x1,x6,x9 0.0346 x1,x4,x6,x9 0.0065
3 x8 0.2875 x2,x6 0.1198 x2,x6,x9 0.0557 x5,x6,x8,x9 0.0066
4 x3 0.3265 x8,x9 0.1282 x6,x8,x9 0.0611 x3,x5,x6,x9 0.0066
5 x1 0.3492 x1,x6 0.1310 x4,x6,x9 0.0677 x1,x5,x6,x9 0.0067
6 x2 0.3922 x5,x6 0.1322 x3,x6,x9 0.0769 x2,x5,x6,x9 0.0067
7 x5 0.3988 x1,x3 0.1352 x5,x6,x8 0.0922 x4,x5,x6,x9 0.0070
8 x4 0.4357 x3,x6 0.1417 x4,x6,x8 0.0954 x3,x4,x6,x9 0.0318
9 x4,x9 0.1511 x1,x5,x6 0.0966 x1,x6,x8,x9 0.0339
10 x1,x9 0.1569 x1,x3,x6 0.0986 x4,x6,x8,x9 0.0363
Table IV.18. Sigmoid Predictor Ranking by MSE for Gene Cdh1(x7) in Mutated Network
(Top 10 Predictors Shown), Correct Predictor is x5,x6,x9
Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x7 0.1799 x1,x7 0.1581 x3,x5,x7 0.1136 x3,x5,x6,x7 0.1126
2 x4 0.3708 x6,x7 0.2414 x1,x4,x7 0.1214 x1,x3,x5,x7 0.1129
3 x1 0.3714 x4,x7 0.2425 x1,x5,x7 0.1415 x3,x5,x7,x9 0.1133
4 x5 0.4013 x7,x9 0.2481 x1,x3,x7 0.1480 x2,x3,x5,x7 0.1152
5 x6 0.4340 x5,x7 0.2707 x1,x7,x9 0.1511 x1,x4,x5,x7 0.1204
6 x9 0.4369 x3,x7 0.2755 x1,x6,x7 0.1512 x1,x4,x7,x9 0.1209
7 x2 0.4431 x3,x4 0.2755 x1,x2,x7 0.1529 x1,x2,x5,x7 0.1215
8 x3 0.4668 x2,x7 0.2757 x4,x6,x7 0.1696 x1,x3,x4,x7 0.1220
9 x1,x5 0.2876 x2,x6,x7 0.1740 x1,x4,x6,x7 0.1225
10 x3,x5 0.2927 x4,x5,x7 0.1752 x1,x3,x6,x7 0.1237
Table IV.19. Sigmoid Predictor Ranking by MSE for Gene UbcH10(x8) in Mutated Net-
work (Top 10 Predictors Shown), Correct Predictor is x5,x6,x7,x9
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Rank 1 input 2 inputs 3 inputs 4 inputsPredictor MSE Predictor MSE Predictor MSE Predictor MSE
1 x6 0.1868 x6,x7 0.0073 x6,x7,x8 0.0071 x3,x4,x6,x7 0.0061
2 x7 0.1874 x5,x7 0.1219 x5,x6,x7 0.0385 x1,x3,x6,x7 0.0068
3 x3 0.3262 x7,x8 0.1259 x4,x6,x7 0.0617 x2,x6,x7,x8 0.0069
4 x8 0.3465 x3,x7 0.1288 x3,x6,x7 0.0640 x5,x6,x7,x8 0.0070
5 x1 0.4170 x1,x7 0.1481 x2,x6,x7 0.0656 x4,x6,x7,x8 0.0071
6 x4 0.4173 x6,x8 0.1562 x1,x6,x7 0.0671 x1,x6,x7,x8 0.0071
7 x2 0.4183 x3,x6 0.1607 x2,x4,x7 0.0853 x3,x6,x7,x8 0.0072
8 x5 0.4214 x2,x7 0.1624 x2,x3,x7 0.0884 x3,x5,x6,x7 0.0074
9 x5,x6 0.1747 x3,x7,x8 0.0911 x1,x5,x6,x7 0.0074
10 x4,x6 0.1851 x3,x4,x6 0.0984 x4,x5,x6,x7 0.0074
Table IV.20. Sigmoid Predictor Ranking by MSE for Gene CycB(x9) in Mutated Network
(Top 10 Predictors Shown), Correct Predictor is x6,x7
For the mutated mammal network, Table IV.5 through Table IV.12 (linear representa-
tion) and Table IV.13 through Table IV.20 (sigmoid representation) lists the top 10 predic-
tors for genes x2 through x9 respectively as determined by our algorithm. Gene CycD (x1)
not included as this gene is controlled by an extracellular signal and as such is not regu-
lated by any of the other 8 genes in the network. For each target gene, the correct (actual)
predictor is listed in the table captions. Each table shows predictors for a specific target
gene and is organized as follows. The 1 input column lists the 1 input predictors ranked by
their associated MSE from lowest MSE to highest MSE. The top ranked 1 input predictor
has the lowest MSE and therefore is the best fitting 1 input predictor. Similarly, the 2 input
column lists the 2 input predictors ranked by MSE. And so on for the 3 input column and
4 input columns. For example, Table IV.12 lists the predictors for CycB(x9). In the 1 input
column, the best (lowest MSE) 1 input predictor for CycB is x7 with a MSE of 0.123888.
Looking at the 2 input column, the best 2 input predictor is x6,x7 with a MSE of 0.024118.
For CycB, x6,x7 happens to be the actual or correct predictor.
In general, we find the correct predictor is identified as a top rank predictor in one
of the input columns for majority of genes (E2F(x3),CycE(x4),Cdc20(x6),Cdh1(x7), and
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CycB(x9)) in the mutated mammal network. The exceptions are for gene Rb(x2) where
the correct predictor is the sixth ranked predictor in the list, and for genes CycA(x5) and
UbcH10(x8) which have more than 4 inputs, and thus not listed in the tables which only
show up to 4 input predictors.
For gene Rb(x2), the distribution of samples do not completely cover the 4-input state
space, hence several predictors and Zhelgakin functions can closely fit with low error. How-
ever, we observe that while the top rank predictor {x1,x4,x8,x9} is not the correct predictor
{x1,x4,x5,x9}, the top rank predictor does contains 3 of the 4 correct input genes. We make
similar observation with genes CycA(x5) and UbcH10(x8), in that the top rank predictors
contain many of the correct input genes in the actual predictors. This information can be
useful helpful in refining future tests for gene expression measurements.
IV-C.2. Predictor Selection Method
While the algorithm produces a ranked list of predictors for a gene, it may be desirable
to select a single best predictor. As observed from the predictor tables for the mutated
mammal network, the correct predictor is generally the top ranked predictor from either the
1, 2, 3, or 4-input predictor lists. To select which i-input predictor list to choose from, we
use a metric called the resolution ratio Ri, which measures the difference between the top
ranked predictor and second ranked predictor of a gene with i-inputs. The resolution ratio
is defined as the ratio between the second and top ranked gene as shown in Equation 4.3.
Ri = MSEi,second/MSEi,top (4.3)
A high resolution ratio Ri indicates the top rank predictor has significantly lower error
than all other predictors of the same input size, and thus likely to be the correct predictor.
While a low resolution ratio indicates that several predictors (including the top rank pre-
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dictor) have similarly low error due to underfitting of the data (missing some of the input
genes), overfitting of the data (including additional or wrong input genes), or inadequate
sample distribution.
For example, let us assume for gene xi its predictor is x j,xk, or in other words the target
gene xi is regulated by two input genes x j and xk. Given adequate expression samples, we
expect the MSE of the 2-input predictor x j,xk will be low since this is the actual predictor,
while any other 2-input predictors for xi will have a high MSE. As such, the resolution ratio
for this 2-input predictor R2 will be expected to be high. Now let us consider the underfit
situation. For the target gene xi, we expect either the 1-input predictor x j or the 1-input
predictor xk will have low MSE as both predictors contain input genes from the actual
predictor x j,xk. However, as the MSE of these two predictors will be similar, the resolution
ratio for the 1-input predictor R1 will be low. Next, we consider the overfit situaton. For
the target gene xi, we expect any 3-input or larger predictor that contains x j,xk as a subset
will have low MSE since the that subset is the actual predicotr, while any additional input
genes add only noise. As a result, several predictors will have similarly low MSE and the
resolution ratio R3 will again be low.
Our selection method determines the resolution ratio of all top rank predictors for each
input size, and then selects the top rank predictor with the highest resolution ratio.
Gene p1,top R1 p2,top R2 p3,top R3 p4,top R4
x2 Rb x1 1.394 x1,x4 1.407 x1,x4,x9 1.021 x1,x4,x8,x9 1.034
x3 E2F x7 1.047 x2,x9 1.009 x2,x5,x9 1.262 x2,x5,x8,x9 1.156
x4 CycE x3 1.177 x2,x3 3.827 x2,x3,x5 1.222 x1,x2,x3,x7 1.227
x5 CycA x6 1.006 x2,x6 1.228 x2,x6,x7 1.009 x2,x6,x8,x9 1.019
x6 Cdc20 x9 17.494 x1,x9 1.255 x1,x4,x9 1.031 x3,x4,x7,x9 1.029
x7 Cdh1 x6 1.064 x6,x9 1.707 x5,x6,x9 1.384 x5,x6,x8,x9 1.408
x8 UbcH10 x7 1.959 x1,x7 1.037 x1,x4,x7 1.037 x1,x3,x6,x7 1.036
x9 CycB x7 1.212 x6,x7 3.373 x6,x7,x8 1.982 x3,x6,x7,x8 1.035
Table IV.21. Resolution Ratio Ri for Top Rank Predictors from Mutated Network (Linear
Representation)
90
Gene p1,top R1 p2,top R2 p3,top R3 p4,top R4
x2 Rb x1 1.034 x1,x4 1.185 x1,x4,x9 1.597 x1,x4,x7,x9 1.005
x3 E2F x2 1.013 x2,x5 2.046 x2,x5,x9 9.160 x2,x5,x7,x9 1.032
x4 CycE x3 1.547 x2,x3 81.104 x2,x3,x6 1.302 x1,x2,x3,x7 1.056
x5 CycA x3 1.010 x2,x6 1.388 x2,x6,x8 1.032 x2,x3,x6,x8 3.659
x6 Cdc20 x9 298.041 x1,x9 1.005 x2,x4,x9 1.112 x1,x3,x5,x9 1.080
x7 Cdh1 x6 1.058 x6,x9 2.720 x5,x6,x9 5.007 x1,x3,x6,x9 1.052
x8 UbcH10 x7 2.061 x1,x7 1.526 x3,x5,x7 1.058 x3,x5,x6,x7 1.002
x9 CycB x6 1.003 x6,x7 16.578 x6,x7,x8 5.424 x3,x4,x6,x7 1.114
Table IV.22. Resolution Ratio Ri for Top Rank Predictors from Mutated Network (Sigmoid
Representation)
Gene Correct Predictor Selected Predictor Selected Predictor
(linear) (sigmoid)
x2 Rb x1,x4,x5,x9 x1,x4 x1,x4,x9
x3 E2F x2,x5,x9 x2,x5,x9 x2,x5,x9
x4 CycE x2,x3 x2,x3 x2,x3
x5 CycA x2,x3,x6,x7,x8 x2,x6 x2,x3,x6,x8
x6 Cdc20 x9 x9 x9
x7 Cdh1 x5,x6,x9 x6,x9 x5,x6,x9
x8 UbcH10 x5,x6,x7,x9 x7 x7
x9 CycB x6,x7 x6,x7 x6,x7
correct 4 5
Table IV.23. Comparison of Selected Predictors Using Highest Ri for Mutated Network
Table IV.21 (linear) and Table IV.22 (sigmoid) lists all the resolution ratios and top
rank predictors for the mutated mammal cell cycle network. The selected predictors for
each gene as chosen by our method is shown in Table IV.23. In general, we find the ma-
jority of selected predictors are the correct predictors for genes with adequate expression
sampling. Also, we find higher number of correctly select predictors using the sigmoid
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representation for gene expression values.
IV-C.3. Melanoma Network
Based on the results from the mutated mammal cell-cycle network using synthetic data, we
evaluate our predictor ranking and selection algorithms to the actual data from a melanoma
network study [32]. This study identified seven genes PIRIN, S100P, RET 1, MART1,
HADHB, STC2, and W NT 5A, to be closely related with the metastasis of melanoma.
From [32], 31 gene expression lines (states) were measured, and then reduced to seven
distinct lines (shown in Table IV.24).
PIRIN S100P RET 1 MART 1 HADHB STC2 WNT 5A
x1 x2 x3 x4 x5 x6 x7
0.002 0.020 0.275 0.010 0.227 1.000 1.000
0.056 0.000 0.239 0.011 0.430 0.583 0.318
0.387 0.006 0.440 0.008 0.070 0.055 0.511
0.137 0.147 0.156 0.005 0.227 0.014 0.026
0.222 0.168 0.532 0.141 0.395 0.000 0.000
0.751 0.016 0.349 0.152 0.564 0.197 0.005
0.401 0.411 0.028 0.778 0.663 0.016 0.018
Table IV.24. Normalized Gene Expression Lines for Melanoma Network
We apply our ranking algorithm on each gene x1 to x7 in the melanoma network and
show the results in Table IV.25 through Table IV.31 respectively. From [27] which inferred
the predictor set on the binary valued melanoma gene expression data, we observed that
one of the attractor cycle ordering is common to the majority of predictor selection results.
This attractor cycle ordering is used along with the normalized gene expression data in our
algorithm.
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Due to the limited sample size of 7 states, we limit the algorithm to search predictors
up to 3 input genes. Similar to assumptions made in the mutated mammal network, this
is a reasonable constraint as most genes have been observed to be regulated by few input
genes.
Rank 1 input 2 inputs 3 inputsPredictor MSE Predictor MSE Predictor MSE
1 x4 0.012746 x2,x4 0.012406 x3,x4,x7 0.007550
2 x5 0.054450 x4,x6 0.012765 x3,x4,x5 0.010336
3 x2 0.082764 x4,x7 0.012824 x2,x4,x5 0.012355
4 x3 0.181548 x3,x4 0.012928 x2,x3,x4 0.012401
5 x7 0.294790 x4,x5 0.014873 x2,x4,x6 0.012401
6 x6 0.357402 x3,x5 0.037186 x2,x4,x7 0.012402
7 x5,x6 0.040313 x4,x5,x7 0.012740
8 x5,x7 0.051799 x4,x6,x7 0.012747
9 x2,x5 0.054959 x3,x4,x6 0.012750
10 x2,x6 0.082925 x4,x5,x6 0.012755
Table IV.25. Predictor Ranking by MSE for Gene PIRIN(x1) in Melanoma Network (Top
10 Predictors Shown)
Rank 1 input 2 inputs 3 inputsPredictor MSE Predictor MSE Predictor MSE
1 x3 0.066051 x1,x3 0.002817 x1,x5,x7 0.001633
2 x1 0.082764 x3,x5 0.005744 x1,x3,x6 0.002146
3 x4 0.140740 x1,x5 0.006163 x1,x3,x7 0.002355
4 x5 0.153993 x1,x6 0.007762 x1,x3,x5 0.002661
5 x7 0.191924 x3,x4 0.009302 x1,x3,x4 0.002848
6 x6 0.224416 x4,x6 0.009450 x3,x5,x7 0.005743
7 x4,x7 0.009475 x3,x4,x5 0.005754
8 x5,x7 0.009613 x3,x5,x6 0.005834
9 x3,x6 0.009832 x1,x4,x5 0.005978
10 x1,x7 0.010902 x1,x5,x6 0.006015
Table IV.26. Predictor Ranking by MSE for Gene S100P(x2) in Melanoma Network (Top
10 Predictors Shown)
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Rank 1 input 2 inputs 3 inputsPredictor MSE Predictor MSE Predictor MSE
1 x2 0.066051 x6,x7 0.059060 x1,x6,x7 0.054525
2 x4 0.163481 x1,x7 0.061057 x2,x6,x7 0.055919
3 x1 0.181548 x1,x2 0.064650 x1,x2,x7 0.056163
4 x7 0.183881 x2,x5 0.065870 x5,x6,x7 0.058549
5 x5 0.218690 x1,x5 0.066056 x4,x6,x7 0.058892
6 x6 0.260163 x2,x6 0.066109 x1,x4,x7 0.059260
7 x4,x5 0.066131 x1,x5,x7 0.060139
8 x2,x7 0.066222 x1,x2,x5 0.062339
9 x2,x4 0.066566 x2,x4,x5 0.063420
10 x1,x4 0.067849 x1,x4,x5 0.063754
Table IV.27. Predictor Ranking by MSE for Gene RET 1(x3) in Melanoma Network (Top
10 Predictors Shown)
Rank 1 input 2 inputs 3 inputsPredictor MSE Predictor MSE Predictor MSE
1 x1 0.012746 x1,x7 0.008141 x1,x2,x7 0.004954
2 x5 0.137126 x1,x2 0.009512 x1,x6,x7 0.008154
3 x2 0.140740 x1,x3 0.012364 x1,x5,x7 0.008190
4 x3 0.163481 x1,x6 0.012821 x1,x2,x3 0.009267
5 x7 0.315267 x1,x5 0.019267 x1,x3,x7 0.009269
6 x6 0.343011 x2,x5 0.088936 x1,x2,x6 0.009520
7 x3,x5 0.110609 x1,x3,x5 0.009832
8 x5,x6 0.125847 x1,x2,x5 0.009886
9 x3,x6 0.132900 x1,x3,x6 0.012235
10 x5,x7 0.133036 x1,x5,x6 0.012721
Table IV.28. Predictor Ranking by MSE for Gene MART 1(x4) in Melanoma Network (Top
10 Predictors Shown)
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Rank 1 input 2 inputs 3 inputsPredictor MSE Predictor MSE Predictor MSE
1 x1 0.054450 x1,x4 0.025557 x1,x4,x7 0.021039
2 x4 0.137126 x1,x2 0.033795 x1,x3,x4 0.022426
3 x2 0.153993 x1,x7 0.050079 x1,x2,x4 0.024602
4 x3 0.218690 x1,x3 0.051083 x1,x4,x6 0.025467
5 x7 0.315565 x1,x6 0.054356 x1,x2,x7 0.029309
6 x6 0.334355 x2,x4 0.124102 x1,x2,x3 0.030218
7 x4,x7 0.136953 x1,x2,x6 0.033643
8 x4,x6 0.137194 x1,x3,x6 0.048583
9 x3,x4 0.137458 x1,x3,x7 0.049295
10 x2,x7 0.154147 x1,x6,x7 0.049949
Table IV.29. Predictor Ranking by MSE for Gene HADHB(x5) in Melanoma Network (Top
10 Predictors Shown)
Rank 1 input 2 inputs 3 inputsPredictor MSE Predictor MSE Predictor MSE
1 x7 0.096190 x3,x7 0.075564 x1,x3,x7 0.069109
2 x2 0.224416 x1,x7 0.081605 x3,x5,x7 0.075394
3 x3 0.260163 x2,x7 0.096030 x2,x3,x7 0.075572
4 x5 0.334355 x4,x7 0.096044 x3,x4,x7 0.075572
5 x4 0.343011 x5,x7 0.101558 x1,x2,x7 0.081524
6 x1 0.357402 x2,x4 0.216856 x1,x4,x7 0.081537
7 x2,x5 0.216989 x1,x5,x7 0.081647
8 x3,x5 0.218127 x2,x4,x7 0.095690
9 x3,x4 0.218175 x2,x5,x7 0.095914
10 x2,x3 0.218195 x4,x5,x7 0.096012
Table IV.30. Predictor Ranking by MSE for Gene STC2(x6) in Melanoma Network (Top 10
Predictors Shown)
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Rank 1 input 2 inputs 3 inputsPredictor MSE Predictor MSE Predictor MSE
1 x6 0.096190 x5,x6 0.063681 x1,x5,x6 0.051371
2 x3 0.183881 x3,x6 0.091656 x3,x5,x6 0.060039
3 x2 0.191924 x1,x6 0.095633 x2,x5,x6 0.063405
4 x1 0.294790 x4,x6 0.095824 x4,x5,x6 0.063546
5 x4 0.315267 x2,x6 0.095870 x1,x3,x6 0.084099
6 x5 0.315565 x3,x5 0.162585 x3,x4,x6 0.091255
7 x1,x5 0.171238 x2,x3,x6 0.091303
8 x1,x3 0.176896 x1,x4,x6 0.095274
9 x2,x3 0.182140 x1,x2,x6 0.095318
10 x3,x4 0.182581 x2,x4,x6 0.095329
Table IV.31. Predictor Ranking by MSE for Gene WNT 5A(x7) in Melanoma Network (Top
10 Predictors Shown)
From the predictor rankings, we apply our selection method based on MSE and res-
olution ratio and find the best predictors for each gene. The selected predictors are shown
in Table IV.32 and these results can provide direction for further validation in lab experi-
ments. In addition, our algorithm also returns the associated Zhegalkin function along with
the selected predictor, also shown in Table IV.32.
Gene Selected Predictor Zhegalkin function
x1 PIRIN x3,x4,x7 x4 + x3x7− x4x7
x2 S100P x1,x3 x1x3
x3 RET 1 x1,x6,x7 x7− x1x7− x6x7 +2x1x6x7
x4 MART 1 x1,x2,x7 x1− x1x2− x1x7 + x1x2x7
x5 HADHB x1,x4 x1 + x4−2x1x4
x6 STC2 x1,x3,x7 x7− x1x7− x3x7 + x1x3x7
x7 W NT 5A x1,x5,x6 x1 + x6− x1x5−2x1x6− x5x6 +2x1x5x6
Table IV.32. Predictor Selection for Melanoma Network
For example, let us examine the predictor selected for WNT5A. In [32], the expression
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of WNT5A was observed to been associated with the metastasis of melanoma, so determin-
ing the predictors of WNT5A is of great interest for GRN control and intervention. Our
algorithm finds the best predictor (predictor containing Zhelgakin function with least er-
ror) for WNT5A to be x1,x5,x6, or in other words PIRIN, HADHB, and STC2, the results
of which appear consistent with literature [2, 60]. From our algorithm, the corresponding
Zhegalkin function for WNT5A is x1 + x6 − x1x5−2x1x6− x5x6 +2x1x5x6, which we can
convert to the Boolean function HADHB(PIRIN⊕STC2). These findings can be used by
biologists to develop drugs that target PIRIN, HADHB, and STC2 to modify the expression
of WNT 5A and control the metastasis of melanoma.
IV-D. Chapter Summary
In this chapter, we have presented a method for inferring and ranking predictors from nor-
malized continuous gene expression data using Zhegalkin functions. Our algorithm ex-
plores all possible predictor combinations for a target gene and measures the error of each
predictor based on its best fitting Boolean logic function (represented as a Zhegalkin func-
tion) upon the gene expression data (linear or sigmoid representation). The predictors are
then ranked by error to determine a list of top predictors for the target gene, from which
a single predictor can be chosen, or can be used to guide future expression measurement
experiments. We validate our Zhegalkin predictor inference method on synthetic data from
the mutated mammalian network and show how results can be used to rank and select pre-
dictors for genes. We also demonstrate our method on actual data from melanoma network.
Additionally, the ranked list can be used to improve predictor set inference (see Chap-
ter 2) by assigning weights to predictors relative to the MSE. The SAT formulation can
be modified to a Weighted Partial Max-SAT (WPMS) formulation to select predictors that
satisfy GRN constraints as well as minimizing the overall MSE weights.
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The work presented in this and preceding chapters have focused on inferring the GRN
using logic synthesis tools. An accurate representation of the GRN is necessary to under-
stand how genes are regulated in a system, how regulation can fail leading to disease, and
more importantly, how to control the GRN to treat the disease. In the next chapter, we
look at applying logic synthesis to the problem of GRN control. In particular, cancer is
described in the stuck-at fault model, and weighted partial Max-SAT algorithms based on
ATPG techniques are used to determine optimum drug selection for cancer therapy.
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CHAPTER V
ATPG FOR CANCER THERAPY
Cancer and other gene related diseases are usually caused by a failure in the signaling
pathway between genes and cells. These failures can occur in different areas of the gene
regulatory network, but can be abstracted as faults in the regulatory function. For effective
cancer treatment, it is imperative to identify faults and select appropriate drugs to treat
the faults. In this chapter, we present an extensible Max-SAT based automatic test pattern
generation (ATPG) algorithm for cancer therapy [30, 31]. This ATPG algorithm is based on
Boolean Satisfiability (SAT) and utilizes the stuck-at fault model for representing signaling
faults. A weighted partial Max-SAT formulation is used to enable efficient selection of the
most effective drug.
Several usage cases are presented for fault identification and drug selection. These
cases include the identification of testable faults, optimal drug selection for single/multiple
known faults, and optimal drug selection for overall fault coverage. Experimental results
on growth factor (GF) signaling pathways demonstrate that our algorithm is flexible, and
can yield an exact solution for each feature in much less than 1 second.
1
V-A. Background
In all organisms, cell function is supported by the interaction of genes and protein products,
forming an interconnected network called the gene regulatory network (GRN) [33]. The
interaction or communication between genes and cells is highly complex and multivariate.
Cancer and gene-related diseases are often the result of a failure in the signaling, leading
1Part of the data reported in this chapter is reprinted with permission from ”Efficient Cancer
Therapy using Boolean Networks and Max-SAT-based ATPG” by Pey-Chang Kent Lin,
Sunil P. Khatri. IEEE International Workshop on Genomic Signal Processing and Statistics
(GENSIPS) 2011, Dec. 2011, pp. 97-90, Copyright 2011 by IEEE
99
to incorrect gene regulation and its associated functions.
The modeling of the gene interactions is thus highly important for understanding the
mechanism and therapy of cancer. Because genes are observed to have a switch-like expres-
sion (active or inactive), the Boolean network model [12] has become popular for represent-
ing the GRN. In the Boolean network, the genes and biochemical pathways are represented
as logic functions, much like logic gates in an integrated circuit (IC). This network can be
extended to include signaling failures and defects in the GRN, which are represented as
faulty lines in the circuit [42].
The issue of faults in circuits is well understood in electronic testing. For example, in
chip manufacturing, circuits are typically tested to check that the IC is defect free before
shipment to vendors. Manufacturing defects manifest themselves as logical faults modeled
as lines (wires) stuck-at ‘1‘ or ‘0‘. Using this stuck-at fault model, automatic test pattern
generation (ATPG) algorithms determine a set of tests (bit vectors on the inputs of the
circuit) to test for stuck-at faults in the circuit.
In this chapter, we use the stuck-at fault model for the GRN [42] and employ ATPG
techniques to determine a drug vector (set of drugs) to rectify the fault. The ATPG al-
gorithm is developed as a Boolean satisfiability (SAT) based method, where the Boolean
network is transformed into a conjunctive normal form (CNF) expression and solved for
satisfiability to find the drug vector. In therapy, the goal is to treat the cancer (represented
by one or more faults) using drugs with the least negative impact on the patient, ideally
by prescribing the fewest number of drugs necessary to avoid unnecessary side-effects and
cost. The SAT method is further extended by assigning weights to the circuit outputs and
drug vectors, and solved with a weighted partial Max-SAT to find the optimal set of drugs
to fix or rectify the fault.
The key contributions of this chapter are:
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• In contrast to previous approaches [42] which performs an explicit search, we de-
velop an implicit SAT-based ATPG approach to model and identify detectable faults
(single and multiple) in a Boolean network.
• By assigning weights to model output and drug vectors, we use a weighted partial
Max-SAT formulation to determine the optimum selection of drugs to rectify a spe-
cific fault.
• Our approach can be trivially extended to handle multiple faults.
• We utilize the above techniques for drug therapy to select the minimum set of drugs
to provide the best coverage across all single/multiple faults.
V-B. Previous work
In the actual GRN, the gene expression or protein concentration is continuous. However, in
our method, the Boolean network (BN) [12] is chosen as preferred network for modeling
the GRN. There are several reasons for this choice. First, it has been observed that many
genes exhibit a switch-like ON/OFF activity in terms of their expression [19]. Second, a
discrete model like the BN is relatively simple and easy to analyze and simulate. And lastly,
there are many logic synthesis and test algorithms already developed in circuit design and
testing that can be applied to the Boolean network.
In [42], the authors proposed modeling cancer as faults in the signaling network and
applied fault analysis for drug intervention to control the GRN. Cancer is a disease that
arise from fault(s) in the network leading to loss of cell cycle control and uncontrolled
cell proliferation. Therapy involves both identification of the fault and a suitable drug
combination to target the fault. To test our method, we focused on the growth factor (GF)
signaling pathways, which are often associated with proliferation of cancer. The GRN
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is modeled using Boolean logic gates and all possible single faults are enumerated. All
drug combinations were also simulated to determine the effectiveness of drug combinations
towards each fault.
The method proposed in [42] is an ATPG technique in principle. Our approach is
similar to [42] in that it uses the BN and models cancer as faults in the network. However,
the differences are several. Instead of explicit enumeration of the BN, we use an extensible,
implicit SAT-based ATPG approach to efficiently model and identify faults, and perform
drug selection. Further, unlike [42], we include weighted clauses for outputs and drugs in
the SAT formulation. Using this, the algorithm can implicitly and efficiently determine the
drug combination which is maximally effective. Finally, our approach can handle multiple
faults easily. The runtimes of our approach are typically much less than a second per set of
faults.
In the past, ATPG has been extensively studied in research and industry. One such
ATPG technique is the SAT-based ATPG [61, 62, 63] which translates the testing condition
into a SAT instance that retains the circuit structure. A test for the fault can then be found by
invoking a SAT solver. In the context of cancer therapy, we extend the SAT based approach
to handle drugs and multiple faults.
SAT-based approaches have been applied to the analysis of GRNs and Boolean net-
works. In [27, 31], SAT-based approaches are presented to infer gene predictors and de-
termine gene function from gene expression data using a BN model. Another SAT-based
approach for GRN inference is presented in [50]. Assuming an asynchronous logical de-
scription of the GRN, [50] expresses GRN constraints into a Boolean formula, from which
they infer parameters of the GRN. While in [51], an algorithm is presented to find all attrac-
tors in a Boolean network based on a SAT-based bounded model checking. This algorithm
uses a SAT-solver to identify paths of a particular length in the state-transition graph of a
Boolean network. In these previous works, SAT has been used to infer the GRN. This fun-
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damentally differs from our work which uses SAT to simulate the faulty GRN and control
the GRN using drugs.
Control of Boolean networks has been studied from a theoretical standpoint in [64]
and using a model checking algorithm in [65]. In these papers, a BN with control nodes is
given, and the control strategy denotes a sequence of control signals that deterministically
drive the BN from a given initial state, to a desired final state, in t time steps. Conceptually,
our SAT-based ATPG approach is similar to these methods of Boolean network control, in
that we construct a SAT formula to check whether a selection of drugs can drive the system
to a desired state. However we differ in a few key areas. First, our approach considers the
BN under a stuck-at fault model, in that one or more of the genes can be faulty. This model
allows us to apply ATPG techniques to identify faulty genes in the BN which can lead
to undesired GRN behavior. And secondly, our approach weighs the drugs and outputs
in the ATPG formulation, allowing for different control strategies depending on desired
specifications (i.e. selection with fewest drugs or fewest side effects). Unlike [64, 65], our
method can also determine the best drug selection on a BN where the faulty gene location
is unknown.
V-C. Method
In this section, we present our SAT-based ATPG method. Before the method is described
in detail, we first provide definitions for fault modeling and Boolean Satisfiability.
V-C.1. Fault Terminology
Definition V.1: A manifestation of a defect at the abstracted function level is called a fault.
In an IC, the difference between a defect and a fault can be explained as imperfections
in the hardware and function, respectively. While in genomics, examples of biological de-
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fects can include mutations in the gene activation site, malformation of the protein folding,
and problems in the gene product transport. Likewise, an example of a biological fault is a
modification of the logical function representing a gene, producing the incorrect output.
Definition V.2: A stuck-at fault is modeled by assigning a fixed (0 or 1) value to a
signal line (input or output of a logic gate) in the circuit.
Definition V.3: An untestable fault is a fault which no test can detect. Untestable
faults appear in two situations.
• Faults that are redundant, whose presence does not change the output behavior of the
circuit.
• Faults that change the output behavior of the circuit, but no test (drug vector in the
context of cancer therapy) can be generated to propagate or rectify the fault.
V-C.2. Stuck-at Fault Modeling
In the Boolean network model for a GRN, the activity of genes is modeled as a Boolean
circuit. We assume the circuit is modeled as an interconnection of Boolean gates. A stuck-
at fault is assumed to only affect interconnections (wires or nets) between gates. Each net
can have one of two types of faults: stuck-at-1 or stuck-at-0 (s-a-1 and s-a-0, respectively).
Thus, a net with a stuck-at-0 fault will always have a logic value 0, irrespective of the
correct logic output of the gate (gene) driving the net.
c
a
b
s−a−1
1
0
0
0/1
0/1
Fig. V.1. Circuit with stuck-at fault
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As an example, consider the circuit of Figure V.1 comprising of an OR gate driving
an AND gate. Also consider a stuck-at-1 fault at the output of the OR gate, which means
that the faulty line remains 1 irrespective of the input state of the OR gate. If the normal
(good) output of the OR gate is 1 (in the case where its inputs were < bc >= 01,10,11),
then this fault will not affect any signal in the circuit. However, the input < bc >= 00 to
the OR gate should produce a 0 output in the good circuit. The good (faulty) value 0 (1) is
applied to the AND gate. If the input vector < abc >= 100, the good circuit output (true
response) and faulty output would differ. Hence < abc >= 100 is called a test for the s-a-1
fault on the output of the OR gate.
s−a−1
s−a−0
s−a−00
s−a−11
Fig. V.2. Fault modeling and injection
A stuck-at-0 fault is modeled by inserting a two-input AND gate at the fault site as
shown in Figure V.2. The side input of the gate is driven by a signal which is set to 1 to
simulate a fault-free site, or set to 0 to inject the s-a-0 fault. Similarly, the circuit with a
s-a-1 fault is modeled by inserting an OR gate at the site. The side input of this OR gate
is set to 0 to simulate a fault-free site, or set to 1 to inject the s-a-1 fault. These gates are
inserted at every net (wire), allowing the simulator to inject faults at any site.
Note that drugs are modeled the same as stuck-at faults, wherein a drug that inhibits
a gene is modeled as a s-a-0 ”fault”, while a drug that activates a gene is modeled as s-a-1
”fault”. The gates for drug injection are inserted at the nets of the genes that they target.
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V-C.3. SAT-based Formulation for Stuck-at Fault Model
In the SAT based ATPG method, we first generate a formula in CNF to represent tests for
the fault. To do so, the circuit from the stuck-at fault model must be converted to a CNF.
Every gate (gi) of the circuit has CNF formula (Gi) associated with it, which represent the
function performed by the gate. The formula is true if and only if the variables representing
the gate’s inputs and outputs take on values consistent with its truth table.
For example, consider a 2-input AND gate (g j) with the lines x and y as inputs and z
as output. The CNF formula (G j) for the AND gate is written as:
G j = (z+ x) · (z+ y) · (z+ x+ y)
A CNF formula for the entire circuit S is obtained by forming the conjunction of the
CNF formulas for all the gates of the circuit. If there are n gates in the circuit, then the
CNF formula S for the entire circuit is written as:
S =
n
∏
i=1
Gi
When all the s-a-0 and s-a-1 variables are set to false (0), the CNF formula S describes
the good (fault-free) circuit behavior. The faulty circuit is a copy of the fault-free circuit,
with faults (s-a-0 or s-a-1 variables) injected at the gates to be affected by faults.
We explain our approach using a simple example. Assume we are given the BN net-
work from Figure V.1, which has two gates g1 and g2, primary inputs a,b,c, and primary
output z. Also assume and we want to model a stuck-at 1 fault on the output of gate g1 as
shown in the figure. From our stuck at model, we insert an OR gate g3 at that location. We
label the output of g3 as e, which is now an input to gate g2. The gate g3 has two inputs,
d (the output of gate g1) and a side input f . With all inputs and outputs labeled, we obtain
the CNF formula for each gates and the entire circuit.
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G1 = (d+b+ c) · (d+b) · (d+ c)
G2 = (z+a) · (z+ e) · (z+a+ e)
G3 = (e+d + f ) · (e+d) · (e+ f )
S = G1 ·G2 ·G3
The value of f , the side input to gate g3, determines whether the stuck-at 1 fault is
activated or now. To activate the fault, f is set true by adding a clause ( f ) to the CNF, thus
S = G1 ·G2 ·G3 · ( f ). Likewise, to deactivate the fault, f is set false by adding the clause
( f ) to the CNF, thus S = G1 ·G2 ·G3 · ( f ). With our CNF formula for the circuit, we now
describe several usage cases employing this CNF in SAT.
NRG1
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HBEGF
EGFR ERBB2
IGFRIA/B
ERBB2/3
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GRB2/
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Fig. V.3. Logic circuit stuck-at fault model for GF signaling pathways
V-C.4. Implementation of Fault and Drug Simulation
V-C.4.a. Case 1: Single Stuck-at Fault Identification
In this method, we find all single stuck-at faults which are non-redundant, as well as the
faulty outputs that they generate. To proceed with this method, we first simulate the original
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circuit to determine the correct fault-free output. The circuit is simulated using our SAT
formulation in the fault-free and drug-free model for a specified primary input value, and
the resulting primary output value for the true response is saved as Z0.
The next step is to find all faults which are non-redundant. To avoid having to do
an exhaustive search on all single stuck-at faults, we perform an All-SAT on the circuit S
where we constrain the output to be not Z0. Assuming n output signals, this constraint is
formed as the clause C1 shown in Equation 5.1.
C1 = (Z00 +Z01 + · · ·Z0n) (5.1)
Here Z0i is the variable corresponding to the ith output bit.
Furthermore, we also add a constraint to S that the circuit contains only one fault that
is injected at a time. This second constraint C2 (Equation 5.2) is formed by writing clauses
of all pairwise combinations of faults, where k is the number of stuck-at faults and fi is the
ith fault.
C2 = ( f1 + f2) · ( f1+ f3) · · ·( fk−1 + fk) (5.2)
We now form a new CNF S1 = S ·C1 ·C2 which is a conjunction of (Equation 5.1
and 5.2). The resulting All-SAT on S1 is a list of all non-redundant single stuck-at faults
and their faulty output. These faults are flagged for drug simulation using any of the next
three cases.
The results from this case can also be used immediately in several ways. For exam-
ple, this method classifies for each single stuck-at fault whether it is redundant or non-
redundant. That is, any fault which is redundant does not produce an incorrect output, and
can be ignored from a therapy standpoint. In a second example, the faulty output from the
stuck-at model can be compared to a previously measured output from expression data, in
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order to identify which genes are potentially faulty. This information can be used to target
genes for potential drug development, avoiding genes that are untestable.
V-C.4.b. Case 2: Fault Rectification with Fewest Drugs
In the presence of a particular fault, the problem is determining whether a selection of
drugs can rectify the circuit, i.e. change the faulty output to the correct output. If this is not
possible, we want to obtain the ”best” or ”closest” output to the correct output, by using
drugs. To do this, we guide the WPMS solver by assigning weights to the output states. For
example, in the GF network used in our experiments, the fault-free output Z0 is assigned the
highest weight (80) and remaining output states are assigned decreasing weights (70, 60,
50, etc.) based on increasing Hamming distance (1, 2, 3, etc.) from the fault-free output.
We assume that faulty states that have a larger Hamming-distance have a more pronounced
cancer proliferative effect.
Additionally, the selection of drugs to achieve the best output should use the least
number of drugs to minimize the side-effects on the patient. To incorporate this in the
WPMS solver, each drug that is not selected is given a weight of 1. The GF network
example has 6 drugs, thus if no drugs are selected, then the cumulative drug weight is 6.
Likewise, if all drugs are selected, the drug weight is 0.
Note that the output and drug weights are assigned in such a way as to avoid the
situation where a less-desirable output (with few drugs) is chosen over a higher weight
output with more drugs. We assume that from a clinical standpoint, the priority is to first
produce the best possible output, and secondarily to use the fewest drugs required for that
output.
All faulty circuits with non-redundant faults from Case 1 are augmented with the out-
put and drug weights and simulated using WPMS. The WPMS solver will implicitly and de-
terministically find the assignment of drugs that achieves the best possible output and with
109
the fewest drugs. The output values, selected drugs, and highest weight of the fault+drug
circuits are recorded and compared with the drug-free circuits. An immediate result from
this method is that a fault where the fault+drug circuit which obtains its best output with
zero drugs is in fact an untestable fault, wherein no drug combination can improve the
output.
In general, several stuck-at faults can be simultaneously present in the circuit. A circuit
with n lines can have 3n−1 possible stuck line combinations. This is because each line can
be in one of the three states: s-a-1, s-a-0, or fault-free. All combinations (except one which
has all lines in their fault-free state) are counted as faulty. In our implementation, multiple
stuck-at faults can easily be modeled for rectification, by setting one or more lines to their
faulty state.
V-C.4.c. Case 3: Fault Rectification with Minimal Drug Cost
In the previous case, all drugs are equal in terms of their weight. However, there may be
a situation where we would want to differentiate the drugs based on some cost function
based on characteristics such as price, number of side-effects, or ease of availability. For
example, two drugs with few side-effects may be more desirable than one drug with many
side-effects, if both drug selections produce the same output. As such, in the presence of a
particular faulty circuit and desired output, the problem is determining a selection of drugs
with lowest total cost.
Each drug that is not selected is given a weight proportional to its cost. In our example,
we use the number of side-effects as the drug’s cost. All faulty circuits with detectable
faults from Case 2 are modified with the new drug weights. In addition, the output of the
circuit is fixed to the best output as determined in Case 2. These circuits are then solved
using WPMS to obtain the selected drugs with lowest cost.
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V-C.4.d. Case 4: Determining Therapy with Fewest Drugs and Best Coverage
From Case 2, we identify the drug selection that best rectifies a certain fault. However, in
drug therapy, the fault location may be unknown. In this situation, a drug selection that
rectifies all faults (or as many faults as possible) with the fewest drugs, is desirable.
For each faulty circuit (with a single fault), we find all combinations of 1, 2, and 3
drugs that yield the best output from Case 2. This is done by performing a WPMS All-SAT
to find all satisfying drug selections with drug weight greater than or equal to d−3, where
d is the total number of drugs. Each drug selection (or vector) is analyzed to see how many
testable faults are rectified or covered by it. The drug vector with the highest coverage and
fewest drugs is recorded as a best candidate for therapy.
V-D. Results
V-D.1. Model Implementation
We evaluate the WPMS-based ATPG methods on the GRN that models growth factor (GF)
pathways [42]. In multicellular organisms, cell growth and replication is tightly controlled
by the cell cycle control. This system receives signals from other cells which are used to
decide whether the cell should grow. A failure in these signals can lead to unwanted or
unregulated cell growth, leading to cancer. These signaling pathways are well studied, and
several drugs have been developed to target different pathways for cancer therapy.
We begin with a BN model of the GF pathways as derived in [42]. In this model,
pathways are converted to an equivalent BN logic gate. Each interconnection (net) between
logic gates is then assigned a numerical label.
As stated in our approach section,
defects in the GRN are represented as stuck-at faults that permanently set a signal net
to 1 or 0. At each net, the logic gates for injecting a s-a-0 or s-a-1 are inserted. If there is
111
a drug that targets the net, the appropriate logic gates are also inserted. The conversion of
the faults and drug locations to a logic netlist is shown in Figure V.3. The final circuit is
then converted to CNF for further analysis.
In the results, stuck-at faults are referred by the net numbers that are affected (i.e. net
7 s-a-0, means that the signal corresponding to net 7 is stuck-at 0). The network has 5
primary input (PI) signals and 7 primary output (PO) signals. The PIs will be defined as a
5-bit binary vector:
X = [EGF,HBEGF, IGF,NRG1,PTEN]
The POs will be defined as a 7-bit binary vector:
Z = [FOS− JUN,SP1,SRF−ELK1,SRF −ELK4,BCL2,BCL2L1,CCND1]
In all tests, the PIs are fixed to X = 00001 as this input leads to the non-proliferative
output in the fault-free case.
For this network, six drugs are available, defined as a 6-bit vector. Each bit corre-
sponds to a drug, such that a value of 1 on the ith bit indicates that drug i is selected, and a
value of 0 indicates that drug i is not selected. The drug vector is:
D = [lapatinib,AG825,AG1024,U0126,LY249002,Temsirolimus]
All the methods (Case 1 through 4) were implemented using an open-source weighted
partial Max-SAT solver called Maxsatz [66, 67]. Our procedure consists of scripts which
take the initial CNF, selects desired fault variables, sets output and drug weights, and solves
the CNF using Maxsatz. The satisfying assignments are then parsed for the output and drug
vectors, and reported in the results. In all examples listed in this section, the WPMS runtime
was significantly less than 1 second per CNF.
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V-D.2. Simulation Results
V-D.2.a. Case 1: Single Stuck-at Fault Identification
In the single stuck-at fault model, each net was simulated for s-a-0 and s-a-1 with no drugs,
and results compared with the fault-free circuit. For fault-free circuit with X = 00001,
the output vector is Z0 = 0000000. All single nonredundant stuck-at faults, which have
an output different from the fault-free circuit, are recorded and shown in Table V.1. In this
table, the first three columns show the affected net, the stuck-at value, and the faulty output,
respectively.
From this table, we observe that nets 13, 14, and 15 are not listed. The presence of a
fault (s-a-0 or s-a-1) on these nets does not generate an incorrect PO, and as such, these are
redundant faults. From a therapy standpoint, the genes corresponding to these faults can be
ignored.
V-D.2.b. Case 2: Fault Rectification with Fewest drugs
From the results in Case 1, all non-redundant faults are simulated with drugs. The outputs
are first weighted where the fault-free output Z0 = 0000000 has a maximum weight of 80
as it represents a non-proliferative output. All remaining output vectors are given weights
of 80−10h, where h is their Hamming distance from the fault-free output. The drugs are
also given weights where the non-selection of a drug has a weight of 1. With six drugs, the
maximum score is therefore 80+6 = 86.
Table V.1 shows for each non-redundant stuck-at fault, the best output (Column 4),
the drug vector to achieve such output (Column 5), and the weight score (Column 6). We
observe that for many faults, there exists a drug vector that can completely rectify the
fault, and produce a fault-free circuit. Additionally, the corresponding reported drug vector
is minimal in the number of drugs used, which is desirable in therapy usage. We also
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determine that faults on nets 7, 10-15, 18, 19, 23, and 24 are untestable, as no combination
of drugs can produce a change in the output. This can be explained as there are no drugs
on the fan-out (downstream) of these genes to rectify the fault.
To demonstrate the adaptability of our algorithm, we test it on a few examples of
multiple stuck-at faults. Table V.2 shows for a circuit with multiple stuck-at faults, the best
drug selection for fault rectification (when possible). The columns of Table V.2 have the
same meaning as in Table V.1.
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Net s-a Faulty PO Best PO Drug Vector Score
1 1 1111111 0000000 010000 85
2 1 1111111 0000000 100000 85
3 1 1111111 0000000 001000 85
4 1 1111111 0000000 010000 85
5 1 1111111 0000000 000110 84
6 1 0000111 0000000 000110 84
7 1 0000111 0000111 000000 56
8 1 1111111 0000000 000010 85
9 1 0000111 0000000 000010 85
10 1 0000111 0000111 000000 56
11 1 0000111 0000111 000000 56
12 1 0000111 0000111 000000 56
16 1 0111110 0000000 000100 85
17 1 0111110 0000000 000100 85
18 1 0111110 0111110 000000 36
19 0 0000001 0000001 000000 76
20 0 0000110 0000000 000001 85
21 1 0000110 0000000 000001 85
22 1 0000110 0000000 000001 85
23 1 0000110 0000110 000000 66
24 0 0000110 0000110 000000 66
Table V.1. Drug Selection for Single Stuck-at Faults
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Net s-a Faulty PO Best PO Drug Vector Score
1,21 1,1 1111111 0000000 010001 84
4,9 1,1 1111111 0000000 000001 85
5,19 1,0 1111111 0000001 000110 74
6,8 1,1 1111111 0000000 000110 84
7,20 1,1 0000111 0000111 000000 56
8,21 1,0 0000111 0000000 000010 85
13,16 1,1 1111110 0000000 000100 85
1,3,6 1,0,1 1111111 0000000 000110 84
2,14,20 1,1,0 1111111 0000000 100001 84
4,7,17 1,1,1 1111111 0000111 010100 54
4,12,23 1,1,1 1111111 0000111 010000 55
8,9,11 1,1,1 0000111 0000111 000000 56
8,9,21 1,1,0 0000111 0000000 000010 85
12,18,20 0,0,0 0000110 0000000 000001 85
15,17,21 0,0,1 0000110 0000000 000001 85
Table V.2. Drug Selection for Multiple Stuck-at Faults
V-D.2.c. Case 3: Fault Rectification with Minimal Drug Cost
When selecting drugs, there may be multiple drug combinations that may rectify a fault, but
where each drug has a different associated cost. We first assign weights to drugs, according
to their cost. For this case, we use the number of side-effects as the drug’s cost. Drugs
AG825, lapatinib, Temsirolimus are assigned weights of 10, 15, and 35, respectively, which
correspond to their approximate number of side-effects [68, 69]. However, drugs AG1024,
U0126, and LY294002 have yet to under go clinical trial and the number of side-effects
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is unknown. As such, these drugs are assigned a weight 20, which is an average of the 3
previous weights.
In this GF example, Case 3 simulation provides the same results as in Case 2. This is
due to a lack of drugs that share paths in the circuit. In fact, for almost every non-redundant
fault, the best output state can only be achieved through one drug vector.
V-D.2.d. Case 4: Determining Therapy with Fewest Drugs and Best Coverage
Using the results from Case 2, we observe that the GF network has 13 testable faults. For
these 13 faults, we perform an All-SAT to find the top three scoring drug combinations
yielding the best output. All drug combinations are analyzed across all single faults and
presented in Table V.3 showing drug vector, count of faults rectified, and fault coverage.
Drug vectors are ordered in increasing number of drugs selected.
From these results, we observe that with only 1 drug selected, the best coverage is
only 23% of faults using lapatinib (d1) or Temsirolimus (d6). When allowing for 2 drugs,
coverage increases to 77% using the drug combination of U0126 (d4) and LY294002 (d5).
Finally, we achieve 100% coverage of all testable faults when using the 3 drug combination
of U0126 (d4), LY294002 (d5), and Temsirolimus (d6). When the single stuck-at fault
location is unknown, these selected drug combinations will be the most effective for therapy
and for preventing the proliferation of cancer.
117
Drug Vector Count Coverage Drug Vector Count Coverage
000001 3 23% 000111 13 100%
000010 2 15% 001011 6 46%
000100 2 15% 001101 6 46%
001000 1 8% 001110 10 77%
010000 2 15% 010011 7 54%
100000 3 23% 010101 7 54%
000011 5 38% 010110 10 77%
000101 3 23% 011001 6 46%
000110 10 77% 011010 5 38%
001001 4 31% 011100 5 38%
001010 3 23% 100011 8 62%
001100 3 23% 100101 8 62%
010001 5 38% 100110 10 77%
010010 4 31% 101001 7 54%
010100 4 31% 101010 6 46%
011000 3 23% 101100 6 46%
100001 6 46% 110001 6 46%
100010 5 38% 110010 5 38%
100100 5 38% 110100 5 38%
101000 4 31% 111000 4 31%
110000 3 23%
Table V.3. Drug Selection Count and Fault Coverage
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V-E. Sequential and Feedback Circuits
In this section, we discuss the generalization of our approach to sequential circuits. Thus
far, the SAT-based ATPG algorithm has been described for and performed on purely combi-
national circuits, wherein the primary output of the circuit is dependent only on the primary
inputs. We observe that the output of the GF signaling pathway from the experiment is fixed
based on the primary inputs, where the drug vector is technically also an input. In general
though, the circuit representation of the BN can be sequential, where the primary output is
determined by current state in addition to the input. The local GRN for mammalian cell-
cycle [59] is one such example of a sequential circuit where gene expression updates based
on the current gene state. If we consider a directed graph where the genes are nodes and
edges are regulations upon other genes, then a combinational circuit (such as the GF sig-
naling pathway) is acyclic. However, for a directed graph of a sequential circuit, a subset of
genes will be inter-regulated forming directed cycles. As such, in the BN, a gene takes its
current input (state of its regulatory genes and/or external inputs) and outputs a new state or
value for the next time point. We assume in the BN that all genes update synchronously. In
other words, for each primary input and current state, the resulting primary output and next
state are determined for all genes, and that the next state becomes the new current state.
While a synchronous update is biologically unrealistic, it allows us to have deterministic
state transitions and simplifies the analysis for our ATPG algorithm.
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Fig. V.4. Sequential ATPG by time-frame expansion method
There are several methods for performing sequential ATPG, the most common of
which is Time-Frame expansion [70]. As shown in Figure 4 V.4, the sequential circuit is
replicated m times into a combinational circuit, which models m time steps of the sequen-
tial circuit behavior. The ith copy is connected to the (i+1)th copy such that the regulating
genes from the ith copy are connected to their target genes in the (i+1)th copy. Each copy
is called a frame, and additional frames can be added to the circuit for any length m. In
this way, the sequential circuit is converted to a combinational circuit. After the conversion
of the sequential circuit to a combinational m step expansion, we can apply our SAT-based
ATPG algorithm. When we consider the fault-model of the circuit, we must assume the
fault is persistent (i.e. the fault exists in all frames). The corresponding ATPG method
must target multiple faults, or in other words, the same fault, but in different time frames.
One consideration for the sequential ATPG is the initialization of state in the first
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time frame. Ideally a known state should be used, such as one obtained from a previous
microarray expression measurement. An alternative is to use an attractor state. In the long-
term behavior, the dynamics of the BN transition to the attractors (attractor cycles), thus
using an attractor state is a reasonable starting state for therapy.
The complexity of applying SAT-based ATPG to sequential circuits depends on the
length of time-frame expansion. For a circuit with k variables in its SAT formulation, each
frame increases the number of variables by k. The SAT search space is then 2km for an
expanded circuit with m frames. The number of frames for expansion can be bounded. If a
subsequence of states has the same first and last state, then the sequence can be stopped. For
a BN, the number of frames m can be bounded by the sum of the number of steps it takes to
reach an attractor cycle and the maximum length of the attractor cycles for all combinations
of drugs under consideration. In the worst case, the number of frames required would equal
to the number of possible states, which is 2n+d for a BN with n target genes and d drugs.
V-F. Chapter Summary
In this chapter, we have presented an efficient and extensible SAT-based ATPG methodol-
ogy for cancer therapy. We approach this problem by representing the BN and cancer as
a logic circuit stuck-at fault model. This circuit, along with the testing conditions, is con-
verted into a CNF. The CNF is then augmented with output and drug vectors weights and
solved using a weighted partial Max-SAT solver for four different usage cases: (1) single
stuck-at fault identification, (2) fault rectification with fewest drugs, (3) fault rectification
with minimum drug cost, and (4) determining therapy with fewest drugs and best coverage.
We demonstrate these methods on the growth factor signaling pathway, and have presented
results that are applicable to cancer therapy. While the GF network example in the case
study is a combinational network, our algorithm can easily be extended to address sequen-
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tial networks, like those found in transcriptional GRNs, by simply unrolling the sequential
circuit in time and applying the same methods. Furthermore, all nets, inputs, outputs, and
drugs can be assigned weights, which can be made variable, allowing the user to fine-tune
the network or design therapies for any number of test situations.
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CHAPTER VI
SUMMARY AND FUTURE WORK
VI-A. Summary
With more diseases and health related issues being attributed to genetics, it is imperative to
improve our knowledge of gene regulation within the biological system. While single-point
measurement of gene expression/detection is relatively simple using micro-arrays or gene
chips, measuring or determining the dynamic characteristics of genes in lab is time and
labor intensive. Understanding the dynamic interaction of genes is essential in the medical
field to study and control cancer and other genetic diseases. As a result, in recent times
genomics has become a popular field of research within computational and molecular biol-
ogy, for modeling and analyzing gene networks and regulation. While biological systems
have been observed to exhibit circuit-like properties, there has been little existing work that
exploits logic synthesis to model such systems.
Systems engineering approaches are gradually becoming more accepted and neces-
sary as a means to tackle gene regulatory networks and genetic diseases. In our research,
we show how several techniques from the field of logic synthesis can be used to model,
infer, and control the GRN related to cancer. In particular, this thesis present logic synthe-
sis and SAT based approaches to help infer the predictor sets for GRNs, to determine gene
regulating function, and to determine the ”best” set of drugs for cancer therapy. The results
from these algorithms can be used by clinicians to determine an optimal drug therapy, by
drug developers to target drugs for specific genes, and by biologists to design experiments
to extract specific gene interactions. Our research have applied our approaches and pre-
sented results for gene networks involving melanoma, p53, mammalian, and growth factor
pathways.
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VI-B. Future Work
Our work in applying logic synthesis to GRNs only touches the surface of research in
genomics. But by presenting our interdisciplinary work as part of this PhD effort, we
hope to inspire several additional lines of research using logic synthesis to fundamentally
improve and expand our understanding of gene regulation and control.
The following discussion introduces several genomics research ideas for exploration
using logic synthesis.
1. A key issue in genomics is handling data with error and noise, particularly in mea-
surement of gene expression. One topic is to analyze the GRN behavior which can
lead to measurement of incorrect gene expression. Using the ATPG method dis-
cussed in Chapter 5, we can quantify the sensitivity of a GRN to N ”faults” in the
GRN (where faults represent incorrectly measured data).
2. Another topic of value is to check the logical equivalence of two GRNs (or subsets
of the GRN), using functional equivalence techniques [71]. Such a method may be
useful to identify subsets of GRN between two organisms with the same cellular or
genetic function, or to compare GRNs of patients to determine effective treatment
strategies.
3. Model checking [72], a technique to verify the temporal behavior of logical systems,
can be utilized to query the temporal properties of a GRN in a very efficient manner.
Given the GRN, and given a state that it is currently in, questions such as ”Is there a
way to reach state X in k steps” or ”Is there a way in which state Y is visited infinitely
often in the future” can be answered automatically by model checking systems. This
approach can be useful in cancer therapy to ask questions about a patients prognosis
or determine drug effect on the GRN.
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4. Also in the context of uncertainty modeling, probabilistic Boolean Networks (PBNs) [13]
are used to model the GRN. Suppose there are k BNs which match some observed
data. Then each edge in the PBN has a probability, which is the average of the cor-
responding k edges in the BNs. This can result in the allowing of behaviors that are
not present in any of the k BNs. To avert this issue, Non-Deterministic Finite State
Machine (NDFSM) [73] models of the GRN can be developed. Many techniques
from the field of automata theory can be brought to bear to develop such an NDFSM.
5. Another possible research direction is to perform ATPG on the state transition graph
rather than the logic circuit as we have shown in Chapter 5. Such methods are used
in sequential ATPG and present an a method for drug selection given a GRN with
feedback or sequential properties.
6. As discussed in Chapter 4, gene expression values are initially measured as contin-
uous values. Gene expressions values can then be thresholded to binary value for
use in Boolean logic synthesis algorithms. While Chapter 4 explores using continu-
ous expression values with Zhelgakin function, other alternate logic representations
such as asynchronous logic and multi-valued logic may be valuable in the context of
genomics as well to more accurately represent gene expression values and regulation.
7. The majority of our algorithms utilizes SAT, and as a consequence, the run time of
our approaches is dominated by the SAT solver. Although our algorithms utilize effi-
cient SAT solvers, these solvers are optimized for general or circuit SAT instances. A
possible research topic is understanding and improving SAT solving for GRN prob-
lems. One interesting observation from our SAT implementation in Chapter 2 and 3,
is that the predictor or functions of each gene are encoded in one-hot fashion. A gene
will have many possible predictors or functions, each represented by a Boolean vari-
able, however only one per gene can be selected in the SAT solution. This one-hot
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encoding is a natural fit for accelerating the SAT process on GPU. The implication
for this method of accelerating SAT on GPU extends beyond our algorithm, possibly
lending to SAT research in one-hot and/or multi-valued variables.
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